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In this project, we studied the genetic regulatory mechanisms that affect utilization of 
ethanolamine, an abundant compound in the gastrointestinal environment. In 
Enterococcus faecalis, the ethanolamine utilization (eut) gene cluster encodes for a 
two-component regulatory system (TCS), comprised of a histidine kinase, EutW, 
which autophosphorylates upon sensing EA, and a cognate response regulator, EutV, 
which dimerizes upon receiving the phosphoryl group from EutW and binds the 
nascent transcript to prevent premature transcription termination. This TCS is 
responsible for coupling sensing of ethanolamine to production of eut transcripts. 
However, clues from other organisms had previously suggested that 
adenosylcobalamin (AdoCbl) might also be an important genetic regulatory signal for 
the E. faecalis eut genes. Indeed, we discovered a novel trans-acting noncoding RNA 
(EutX) that contained an AdoCbl-responsive riboswitch. Our data demonstrated that 
  
the riboswitch promotes a shortened form when cellular AdoCbl levels are replete. In 
contrast, a longer form of EutX is synthesized when AdoCbl levels are depleted. We 
demonstrated that structural motifs contained in the longer form of EutX act to 
sequester the EutV protein, preventing it from promoting transcription elongation of 
eut transcripts. These unexpected data revealed an important new type of regulatory 
mechanism for riboswitch RNAs. In support of this overall genetic regulatory model, 
we recapitulated the full genetic circuitry in a heterologous host. Using this system, 
we employed extensive site-directed mutagenesis to examine the functional 
importance of highly conserved EutV residues. This led to the identification of a 
cluster of positively charged residues, which we speculated are important 
determinants for RNA-binding activity. Consistent with this hypothesis, mutations of 
these residues resulted in loss of RNA-binding activity. Furthermore, we also 
explored whether the eut gene cluster was affected by additional genetic regulatory 
mechanisms. From these efforts, we concluded that oxygen is not a genetic regulatory 
feature of eut genes, in contrast to previously published speculation. However, we did 
find that it is likely to be repressed under conditions of high glucose. Therefore, these 
aggregate studies revealed new mechanisms of post-initiation genetic regulation, and 
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Chapter 1: Introduction and literature review 
The ability to sense and respond to sudden changes within an environmental 
niche is essential for all microorganisms. Therefore, microorganisms have evolved 
the ability to respond to environmental changes by specifically altering expression of 
certain genes. The majority of these strategies occur at the level of transcription 
initiation (1); however, recent studies have found many examples of RNA-mediated 
mechanisms that affect gene expression at the post-initiation level (2, 3). In this 
introduction, I will review previous work on representative regulatory RNAs and the 
mechanisms by which they regulate gene expression. I will focus in particular on how 
RNA-mediated control relates to the ethanolamine utilization (eut) gene cluster in the 
Gram-positive bacterium Enterococcus faecalis. 
1.1 Regulatory RNA and post-initiation gene regulation 
 In the past 15 years, many small (~70-500 nt) trans-acting noncoding RNAs 
(‘sRNA’), have been discovered in bacteria (2). Regulatory RNAs employ diverse 
mechanisms to moderate expression of their targets, functioning primarily at the post-
transcriptional level. By using mRNAs as targets, they can affect transcription, 
translation, RNA stability, maturation, and processing (2). In certain instances, 
proteins can be sequestered away from their biological function by sRNAs, 
consequently causing numerous downstream effects (4–8).  
It has been estimated that the number of different sRNAs in a given bacterium 
is likely to be approximately equal to the total number of transcription factors, 




response to different cellular stress signals. Upon induction, some associate with a 
single target mRNA while others target a regulon of different transcripts, oftentimes 
through common seed sequence interactions (10). Although sRNAs have been 
discovered in diverse bacterial species (11) their molecular mechanisms have been 
best characterized in the Gram-negative bacteria Escherichia coli and Salmonella (12, 
13).  
 
1.1.1 Trans-acting Regulatory RNAs: antisense RNAs 
 sRNAs can in principle utilize different types of mechanisms to regulate gene 
expression. Antisense RNAs (asRNAs) can be classified as cis- or trans- effectors, 
depending on whether they are transcribed from the opposite DNA strand of the gene 
that they regulate or from an independent, distal locus in the genome, respectively 
(Figure 1-1). In the case of the cis-asRNAs, complementarity with the target mRNA 
is extensive, while trans-asRNAs tend to exhibit only short stretches of 
complementarity with their targets. In both cases the interactions between the sRNAs 
and their target mRNAs leads to either inhibition or enhancement of mRNA 
translation initiation (e.g., Bacillus subtilis SR1, Staphyloccus aureus RNAIII) and/or 
mRNA degradation (S. aureus RNAIII) (14–21). In contrast to cis-asRNAs that 
usually target one mRNA, trans-asRNAs can target multiple mRNAs. Cis-asRNAs 
are usually constitutively expressed and are primarily associated with mobile genetic 
elements such as plasmids, phages, and transposons. It is here that cis-asRNAs 
regulate plasmid copy number, conjugation, phage life cycle, and transposition (22–








Figure 1-1. Different modes of action for trans-acting regulatory RNAs.  Shown in (A) is an 
example of ‘antisense RNA’ which is typically encoded at the same genomic locus as its target, but is 
transcribed from the opposite DNA strand. Antisense RNAs form longer and more extensive base-
pairing than trans-encoded RNAs with their target mRNAs; they also do not usually require Hfq. 
Examples of protein-sequestering trans-acting RNAs in (B-C). This particular class of RNAs can 
indirectly modulate gene expression by (B) sequestering specific RNA-binding regulatory proteins 
normally required for genetic regulation (e.g., CsrA and RsmA) or (C) direct binding to RNA 
polymerase (e.g., under stationary phase condition), thereby preventing it from initiating transcription. 
Shown in (D) is a more common example of trans-acting RNAs that form imperfect base-pairing with 
sequences within the untranslated region, near the ribosomal binding site, or even within the coding 
region of transcripts. In most cases, a chaperone protein, Hfq, is required for stability and activity of 





the chromosomally-encoded asRNAs are usually induced in response to stress or 
growth-specific conditions (2, 28, 29). Many of these asRNAs have been shown to 
regulate metabolic pathways (29), sugar and carbon source utilization (5), and the 
composition of the bacterial membranes (30–32). Several asRNAs have also been 
found expressed in pathogenic bacteria and their specific roles have been recently 
elucidated (33–35). 
 
1.1.2 Trans-acting Regulatory RNAs: protein-sequestering RNAs 
 Regulatory RNAs also have the ability to bind to proteins and thus regulate 
their activities (Figure 1-1A). This protein sequestration capability has been 
demonstrated for the E. coli CsrB sRNA (targeting the global carbon storage 
regulatory protein, CsrA), and 6S RNA (targeting σ70 RNA polymerase) (4, 5, 36, 
37). These sRNAs are both able to mimic structures of the natural substrates for the 
target proteins and, by doing so, counteract their activity. For example, the E. coli 6S 
RNA mimics an open promoter for association with Sigma 70-RNA polymerase 
holoenzyme, and therefore can titrate transcription complexes away from promoters, 
resulting in a global decrease in transcription. Control of gene expression by 6S RNA 
has been shown to occur in response to the shift from exponential to stationary phase 
growth, suggesting that 6S RNA is an important factor in bacterial adaptation 
processes (37). While CsrB/C and 6S RNAs have been best characterized in E. coli, 
the model Gram-positive bacterium Bacillus subtilis appears to exhibit differences. 
For example, no protein sequestration mechanism like CsrA/B has been identified. 




regulated by growth phase, although their regulatory effects have not yet been studied 
(Figure 1-1B) (38, 39). 
 In E. coli and many Gram-negative bacteria, most of the sRNAs that have 
been mechanistically studied require an RNA-binding protein, Hfq, for their 
regulatory functions (Figure 1-1C). E. coli Hfq is a small (8-15 kDa) protein that self-
assembles into a doughnut-shaped homohexameric complex (40, 41). Multiple RNA-
binding regions are likely to be important for Hfq function as it associates 
simultaneously with an sRNA and its mRNA target (43, 44). Additionally, the C-
terminal extension of the E. coli Hfq constitutes an RNA interaction surface with 
specificity for mRNAs (45). Interestingly, this C-terminal extension is lacking in S. 
aureus, therefore suggesting the protein has lost some RNA binding properties. Hfq 
extends the intracellular half-life of a majority of E. coli sRNAs, but can result in 
shortening of the half-life of target mRNAs after sRNA-bound Hfq associates with 
them (46). However, the role of Hfq in many Gram-positive bacteria is still not well 
understood. Indeed, Hfq has been shown to be dispensable in B. subtilis (15), as well 
as other Gram-positive bacteria (47, 48). Also the relatively few sRNAs characterized 
in these microbes do not require Hfq for stability or activity (49–51).  
In general, the aggregate data on Hfq and CsrA proteins, and the RNAs that 
bind to them, have revealed important information on how RNA binding proteins can 
be generally utilized in bacteria.  
 




 In addition to trans-acting sRNAs, cis-acting regulatory RNAs are prevalent 
in bacteria and are most commonly found in the 5' leader region of mRNAs; however, 
they can also be found within intercistronic regions or in the 3' UTR of a transcript 
(52, 53). Functionally important cis-acting regulatory RNAs have been identified 
most effectively by comparative sequence analyses. This approach can be used to 
identify RNA primary sequences and secondary structures that exhibit significant 
evolutionary conservation (54–56).  
 Some cis-acting regulatory RNAs alter downstream gene expression in 
response to interaction with a particular signaling ligand. These signal-responsive, 
cis-acting regulatory RNAs are called riboswitches (3, 7, 57–59). Many different 
riboswitches have been discovered in bacteria. The signaling ligands that trigger 
regulation by riboswitches range from RNA-binding proteins (3, 58), to trans-RNAs 
(60), to small molecule metabolites or metal ions (7, 61). There are also ‘orphan’ 
riboswitches, which exhibit conservation and phylogenetic patterns that closely 
resemble proven riboswitches, but for whom signaling ligands have not yet been 
identified (3). Riboswitch regulatory RNAs utilize conserved features to fold into 
elaborate three-dimensional structures that bind the cognate ligands with high 
specificity and affinity. Riboswitch RNAs consist of two conceptually distinct 
portions: a ligand-binding domain, commonly referred to as the aptamer domain, and 
an expression platform that is involved in coupling ligand-induced conformational 
changes to genetic control (62).  
 Riboswitches have been discovered that use a range of different molecular 




binding of the appropriate signaling ligand to control of premature transcription 
termination or the efficiency of translation initiation (Figure 1-2A and 1-2B) (3, 63). 
For the former, binding of the ligand to the aptamer domain controls formation of a 
termination site, usually by regulating the formation of a competing, mutually 
exclusive secondary structure (i.e., antiterminator) (3). Analogously, mutually-
exclusive base paired structures are exploited by riboswitches to control ribosome 
access to the ribosome binding site (RBS) or Shine-Dalgarno (SD) sequence, thus 
regulating translation initiation (Figure 1-2C) (58). Some riboswitches affect access 
to an RNase enzyme for signal-dependent control of mRNA stability (64). Finally, 
one particular riboswitch class (glmS) functions as a metabolite-dependent, self-
cleaving ribozyme, which, upon self-cleavage, targets the downstream transcript for 
destruction (65, 66). For most of these mechanisms, the riboswitch RNAs couple a 
swap in Watson-Crick base-pairing schemes to genetic elements that affect 
downstream gene expression.  
 Many riboswitches promote transcription attenuation (Figure 1-2A) (67), 
wherein a metabolic signal is received by the aptamer domain, which in turn 
stimulates the formation of a transcription termination signal. Oftentimes, in the 
termination signal is comprised of an intrinsic terminator helix, which upon formation 
turns downstream gene expression “OFF”. However, in the absence of the metabolic 
signal an alternate ‘antiterminator’ conformation is formed, which actively prevents 
formation of the termination site. It is the ligand-controlled interchange between 
terminator and antiterminator helices that ultimately dictates downstream 








Figure 1-2. Different modes of action for cis-acting RNAs. (A) Control of formation of an intrinsic 
transcription terminator by a metabolite-binding riboswitch. (B) Control of translation initiation 
efficiency by a metabolite-sensing riboswitch. (C) Control of mRNA stability by conformational 








promotes a transcription terminator site and, for those riboswithces, an antiterminator 
configuration is promoted by binding of the metabolic signal to the aptamer domain, 
thereby turning gene expression “ON”. The outcome of these mechanisms is a single 
choice between terminator and antiterminator elements during the process of 
transcription. The outcome of this “choice” between terminator/antiterminator helices 
oftentimes depends on the precise coordination of multiple processes, including the 
nascent RNA folding pathway, ligand-binding kinetics, and the kinetics of 
transcription. Indeed, it has been shown in at least one example that coordination 
between transcription and ligand-binding kinetics is important for gene regulation by 
a number of different regulatory RNAs (68–70). 
 The remaining modes of regulation by which riboswitches regulate genes are 
through translation inhibition and mRNA stability (Figure 1-2B and 1-2C). Similar to 
transcription termination, ligand association influences formation of nucleobase 
pairing interactions between alternate helical pairings. However, instead of 
controlling terminator formation, the RBS is either obstructed from ribosomal access 
or rendered more accessible once the riboswitch is bound by ligand (3, 7). Lastly, 
some riboswitches have also been shown to regulate mRNA stability. For these 
riboswitches, binding of cognate ligand promotes an alternate structure that allows 
access to an RNase enzyme, triggering degradation of the mRNA transcript (71).  
1.2 Genetic regulation of ethanolamine utilization in Enterococcus faecalis 
 The ability to survive in an otherwise hostile environment, such as the 




microorganisms, such as Enterococcus faecalis, have evolved the ability to utilize a 
number of energy sources including ethanolamine (EA), which is richly prevalent in 
the GI tract environment (72–74). In this project, we analyzed several types of 
regulatory RNAs that are required for genetic regulation of E. faecalis ethanolamine 
utilization genes.  
 
1.2.1 Ethanolamine Utilization in Bacteria 
 Enterococcus faecalis is a nosocomial pathogen, prevalent in the hospital 
environment. However, its most common lifestyle is as a commensal in the GI tract of 
mammals. Conversely, in immune-compromised patients this close bacteria-host 
relationship, coupled with E. faecalis’ ability to acquire multiple antibiotic 
resistances, can promote pathogenesis (75). To thrive in the GI tract environment, 
enterococci have evolved the ability to metabolize various energy sources, including 
EA. EA is the byproduct of the catabolism of phosphatidylethanolamine (PE), an 
abundant phospholipid found in both mammalian and bacterial membranes (76).  
Therefore, the combination of both types of cells within the intestine (bacterial and 
epithelial) are thought to provide a rich reservoir of EA (77). Interestingly, several 
bacterial species found within the GI tract, including but not limited to E. faecalis, E. 
coli, Listeria, Salmonella, and Clostridium species, encode the genes necessary for 
EA catabolism.  
 For those organisms that can utilize EA, the central genes in the process of EA 
catabolism are eutB and eutC, the protein products of which form the enzyme 




often found associated with eutBC. They also often include genes that encode for 
alcohol and aldehyde dehydrogenase, and phosphotransacetylase (PTAC) (78). The 
gene clusters for EA utilization have been phylogenetically defined into one cluster 
with three sub-clusters: EUT1, EUT2, and EUT3 (79). EUT1 loci are found in 
enterobacteria and are represented by the experimentally characterized EA utilization 
operon in Salmonella enterica (S. enterica). The EUT2 loci, however, are not as 
clearly defined, due to more variety between the loci. EUT2 sub-types are most 
commonly found in Firmicutes. Finally, EUT3 are found only in two strains of 
Desulfitobacterium hafniense (79). For the EUT1 subfamilies, a DNA-binding 
transcription factor called EutR is routinely associated with the eut gene cluster. 
However, the eutR gene is absent in the EUT2 subfamily and instead the gene cluster 
appears to encode for a two-component regulatory system. Otherwise, all of the eut 
subfamilies largely encode for a similar set of proteins, with only a few few 
exceptions (79). EUT2 loci usually encode for a PduL-like PTAC, while EUT1 loci 
encode the pta-like PTAC, EutD. Additionally, nearly half of the EUT2 loci lack a 
complete cores set of proteins; only sub-type EUT2A encodes for the EutG alcohol 
dehydrogenase, which is responsible for converting an aldehyde to an alcohol. E. 
faecalis falls into this last sub-class of  EA utilization microcompartment gene 
clusters, EUT2A.  
  EA utilization has been most extensively studied in S. typhimurium. In this 
organism, 17 genes encode the proteins involved in EA catabolism and are located 
together on the chromosome in the eut operon (77, 80–82) (Figure 1-3). EutR is the 





Figure 1-3. S. enterica subsp. Typhimurium eut regulation. Top shows the eut operon with two 
promoters, P1 and P2, and the gene for transcription factor EutR highlighted in red. This model, 
adapted from Roof and Roth 1992, proposes that each effector binds independently. Generally, both -
effectors must be present to stabilize the active conformation and ensure sufficient activator for 
induction of the operon. In cells with a high level of EutR, a single effector may generate a large 
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laboratory, established that the primary promoter at the beginning of the eut operon is 
induced in the presence of both EA and adenosylcobalamin (AdoCbl) (83). However, 
a second promoter, found directly in front of the eutR gene, providesconstitutive low-
level expression. While induction of the operon by EutR requires both EA and 
AdoCbl, high-levels of EutR have been shown to cause partial induction with only 
one of the inducers, and an increased maximal expression overall with both EA and 
AdoCbl (83). The exact mechanisms by which AdoCbl and EA activate EutR have 
yet to be elucidated. However, prior experimentation suggested that EutR binds 
directly and simultaneously to both of these compounds, presumably causing a 
conformational change that allows for DNA binding and transcriptional activation by 
EutR (84, 85). 
 
1.2.2 Bacterial Microcompartments and Ethanolamine Catabolism 
 
One characteristic of EA utilization is that all the essential enzymes reside in a 
multi-protein complex termed the bacterial microcompartment. In EA catabolism, the 
formation of a microcompartment is believed to help in retaining the volatile 
intermediate, acetaldehyde, to prevent the loss of this source of carbon and/or protect 
the cell from its potential toxic effects (86, 87).   
In general, bacterial microcompartments are proteinaceous organelle-like 
structures, involved in autotrophic or heterotrophic metabolism (78, 88). There are 
two subtypes of microcompartments: carboxysomes (Figure 1-4), which are involved 
in carbon fixation, and catabolic metabolosomes (Figure 1-4), which share a common 










Figure 1-4. Schematic overview of bacterial microcompartments classes. (A) Carboxysome. (B) 
Metabolosome. An example substrate is EA and the signature enzyme, ethanolamine ammonia lyase, 
produces acetaldehyde and ammonia, a secondary product. Reactions in grey are peripheral to the core 
microcompartment chemistry. Microcompartment shell protein oligomers are depicted on the left: 
black, BMC-H; blue, BMC-T; yellow, BMC-P. CA, carbonic anhydrase; 3-PGA, 3-phosphoglycerate; 















































signature enzymes. The microcompartment shell creates an environment ideal for 
metabolite channeling, sequestering toxic or volatile chemical intermediates, and 
possibly maintaining anaerobic conditions within the microcompartment (89–92). 
Microcompartments are comprised of thousands of subunits including hexameric, 
trimeric, and pentameric structural proteins.  These proteins form a shell that 
encapsulates a catalytic core. The structural proteins of the microcompartment are 
paralogous to the shell proteins of the carboxysome, a bacterial organelle-like 
structure that concentrates CO2 for fixation by ribulose-bisphosphate carboxylase in 
cyanobacteria and many other bacteria (93, 94). The proteinaceous shells of 
microcompartments are similar in that they contain similar bacterial 
microcompartment protein domains (BMC). Indeed, the microcompartments simply 
differ from carboxysomes in the identities of their core enzymes, which are encoded 
from genes that are typically adjacent to shell protein genes within the same gene 
cluster. Bacterial microcompartments are predicted to be present across 23 bacterial 
phyla, and are represented by as many as 23 different types (79, 95). Subtypes of 
metabolosomes contain different core enzymes that perform different metabolic 
functions. There are as many as eight subtypes of catabolic metabolosomes: 1,2-
propanediol utilizing (PDU), Ethanolamine utilizing (EUT), Glycyl radical enzyme-
containing microcompartment (GRM), Planctomycetes and Verrucomicrobia-Type 
(PVM), PVM-like, Ethanol-utilizing (ETU), Metabolosomes of Unknown Function 
(MUF), and Rhodococcus and Mycobacterium microcompartment (RMM) (79). Some 
individual subtypes may be found in multiple organisms. Alternatively, one organism 




for multiple subtypes, such as Clostridium saccharolyticum, which encodes for GRM, 
EUT, and PVM-like microcompartments (79). In certain instances, the functions of 
microcompartments have been associated with a variety of microbial activities, 
including biological nutrient cycling, pathogenesis, and symbiosis (72, 96–99).  
The EA microcompartment shell is constructured from five different Eut proteins, 
encoded by eutS, eutL, eutK, eutM, and eutN genes (82). The ethanolamine ammonia 
lyase, EutBC, cleaves EA to acetaldehyde and ammonia; however, it is not yet known 
whether EutBC is packaged inside the microcompartment or if it resides outside, 
shuttling its byproducts into the lumen of the microcompartment. Some recent data 
suggested the latter (100). This initial breakdown of EA requires AdoCbl as a 
cofactor, which is salvaged by a corrinoid cobalamin adenosyltransferase encoded by 
eutT (101, 102). EutBC’s requirement for AdoCbl may explain why Salmonella EutR 
senses AdoCbl as an important signal for genetic regulation of the eut cluster (83). 
The acetaldehyde produced in the first enzymatic reaction is then converted to acetyl-
CoA by the acetaldehyde dehydrogenase, EutE (72). Acetyl-CoA is subsequently 
used in several metabolic processes including lipid biosynthesis. Conversely, acetyl-
CoA can also be converted into acetylphosphate by the phosphotransacetylase, EutD 
(72). The housekeeping acetate kinase, AckA, then carries out substrate level 
phosphorylation to make acetate from acetylphosphate, with the production of an 
ATP molecule. Alternatively, acetaldehyde can be converted to ethanol by the alcohol 







Figure 1-5. Model for EA catabolism in E. faecalis. (A) E. faecalis eut gene cluster. (B) EA enters 
the cell through diffusion or with the help of EA utilization protein H (EutH). In the EA-specific 
microcompartment (Eut), the structural components of which are EutK, EutL, EutM, EutN, and EutS 
(EutKLMNS), EA is degraded to acetaldehyde and ammonia (NH3) by the EA ammonia lyase 
(EutBC), which requires the cofactor AdoCbl. Acetaldehyde can be catabolized to ethanol by EutG (an 
alcohol dehydrogenase), or to the metabolically useful compound, acetyl-CoA, by EutE (an 
acetaldehyde dehydrogenase). Acetyl-CoA can be used in a range of metabolic processes or converted 
to acetylphosphate by EutD (a phosphotransacetylase). The housekeeping acetate kinase (AckA) can 





































1.2.3 Eut Gene Organization and Content 
 
A study by the Mushegian group on the comparative genomics of EA 
utilization genes found that nearly 100 fully sequenced bacterial genomes contain eut 
gene clusters (103). They determined the content and organizational differences 
among the different phylogenetic groups of those bacteria that contain these genes. 
Organisms with eut gene clusters usually fall into one of two categories: long gene 
cluster or short gene cluster. Actinobacteria, and most Proteobacteria are part of the 
short gene cluster group; consisting only of eutBC and usually the EA transporter, 
eat. However, some of the Proteobacteria also contain an ortholog of the transcription 
regulator eutR at another genomic location, but no apparent orthologs of other eut 
genes.  
On the other hand, the long eut gene clusters are found in Firmicutes and 
Enterobacteriaceae, which include S. typhimurium, E. coli, and E. faecalis (103). In 
the long eut gene cluster there is an arrangement of as many as 17 genes. Intriguingly, 
among the species containing long eut gene clusters, there are substantial differences 
in the exact gene content and organization. Klebsiella pneumoniae, Pseudomonas 
fluorescens, and Marinobacter aquaeolei contain two types of eut gene clusters. K. 
pneumoniae contains a short operon containing eutBC  and eat. P. fluorescens and M. 
aquaeolei contain only eutBC in their short operon. K. pneumoniae also has a 17-gene 
long gene cluster, while M. aquaeolei contains an additional 16-gene long gene 
cluster. P. fluorescens has a second operon containing just eutABC. Of note is that in 
P. fluorescens the two sets of eutBC genes belong to the same gene cluster, but their 




Nearly all the species that contain long eut gene clusters are facultative 
anaerobes that inhabit the gut and/or mouth as either commensals and/or pathogens. 
In comparison, those organisms that have short eut gene clusters tend to be obligate 
aerobes. Based on these differences, it is feasible that the microcompartment is 
important for EA utilization in the GI tract.  
1.2.4 Genetic Regulation of the eut Gene Cluster in E. faecalis 
 
 The gene content and organization of the eut operon in E. faecalis is nearly 
identical to the genes found in S. typhimurium, with a few exceptions. Most 
importantly, E. faecalis lacks the gene encoding for the EutR regulator and contains a 
two-component system, EutW (sensor histidine kinase) and EutV (response 
regulator). The Mushegian laboratory also found that, like E. faecalis, all of the other 
Firmicutes that contain eut gene clusters include the EutV/W two-component system, 
while all the Enterobacteriaceae encode for a EutR regulator.  
 Sensor histidine kinases of two-component systems usually autophosphorylate 
upon sensing a specific signal, and subsequently transfer the phosphoryl group to a 
dedicated response regulator. Phosphorylation of the response regulator usually 
occurs at a conserved aspartate residue on the receiver domain. Upon phosphorylation 
of the response regulator, a conformational change typically takes place, which 
sometimes promotes dimerization, influencing the activity of a second domain, which 
conducts the regulatory response (104). The majority of response regulator output 
domains modulate the activity of various protein-protein interactions, enzymatic 
activity, or DNA-protein interactions (105). However, a small fraction have been 




ANTAR (AmiR and NasR Transcriptional Antiterminator Regulators) domains (106). 
Work on two ANTAR domain-containing proteins, AmiR and NasR, show that these 
proteins interact with their target mRNA transcripts, preventing formation of an 
intrinsic terminator and thereby promoting downstream gene expression (105–109).  
 EutV, much like AmiR and NasR, contains an ANTAR domain at its C-
terminus, and it has been shown that the ANTAR domain disrupts specific intrinsic 
terminators to allow for downstream gene expression (110–114). Additionally, 
eutV/W-associated gene clusters have been identified in several different bacteria, 
including but not limited to Listeria, Clostridium, and Enterococcus species (113). 
Our analysis of these gene clusters also discovered that they were interspersed with 
multiple examples of a putative terminator/antiterminator site. Each of these sites was 
found to be comprised of two, tandem hexanucleotide stem-loops, with the second 
hairpin directly overlapping an intrinsic transcription terminator site (114) (Figure 1-
6A). In E. faecalis, there are four of these two-hairpin motifs, located immediately 
upstream of eutP, eutG, eutS, and eutA (Figure 1-6B), termed P1P2, P5P6, P7P8, and 
P9P10, respectively. Interestingly, the RNA substrates of the two previously 
characterized ANTARs, AmiR and NasR, also have two-hairpin motifs upstream of 
an intrinsic terminator, suggesting that ANTAR domains bind to a common RNA 
element. In support of this, certain nucleotides in the hexanucleotide loops have been 
shown to be important for both NasR and EutV (109, 114–116).  Specifically, an A in 
the first position, and a G at the fourth position within the loop were found to be 












Figure 1-6. Two-hairpin motif ANTAR substrates in E. faecalis eut gene cluster. (A) Alternative 
structures formed by the conserved RNA motif are shown. L1 and L2 denote the two terminal loops 
involved in ANTAR recognition (green). Altered base pairing allows formation of an alternate RNA 
structure that includes a terminator stem-loop (red). (B) Location of the four antitermination sites 










are found in both the Gram-positive bacteria, such as the eut genes of E. faecalis, and 
also the Gram-negative bacteria, such as the ami and nas operons (106, 108, 115). 
 The EutV ANTAR domain alone is sufficient for dimerization (114), although 
an adjacent α-helical region is likely to alter the dimer to improve its RNA-binding 
ability. However, the receiver domain of the EutV response regulator inhibits 
dimerization, and exists as a monomer, when it is in an unphosphoryated state. 
Furthermore, phosphorylation-induced dimerization improved EutV RNA-binding 
affinity (114). This corroborates the previous findings by Baker and Perego where 
they saw a 3-fold increase in transcriptional readthrough of an intrinsic terminator 
upstream of eutG only under phosphorylating conditions of EutV (112). The 
functional importance for dimerization of ANTAR domain-containing proteins is 
further supported by the observation that other classes of ANTAR-containing proteins 
are also likely to form dimers or higher ordered oligomers (114).  
 Deletion of the two-component system prevents expression from a lacZ gene 
when it has been transcriptionally fused to the two-hairpin P1P2 region, highlighting 
the connection between sensing of EA and eut antitermination (113). However, while 
identification of the EutV/W pathway accounts for how eut gene expression responds 
to EA, it was not understood how or if the genes also responded to AdoCbl. Yet, a 
putative AdoCbl riboswitch was discovered in an intergenic region between eutT and 
eutG, upstream of a terminator in front of eutG (112, 113) (Figure 1-7). Previously, 
our lab proposed that this AdoCbl riboswitch served as a 5' UTR for eutG, wherein 
AdoCbl activated antitermination (113). In contrast, the Perego group proposed that 




binding of AdoCbl promoted termination. Together, these data suggested that in the 
Firmicutes, a combination of the two-component system, EA, and AdoCbl participate 
in regulation of eut gene expression. As part of my dissertation research, I chose to 
investigate how E. faecalis utilized the AdoCbl riboswitch to genetically regulate the 




























Figure 1-7. Model for post-initiation control of gene expression in the eut gene cluster of E. 
faecalis. A portion of genes present in the eut gene cluster of E. faecalis are shown (grey boxes) and 
the two-component system, EutVW (purple arrows). A putative AdoCbl-riboswitch is indicated (red) 
within the intergenic region of eutT-eutG. Conserved ANTAR substrates are shown (green). The 
conformation of these ANTAR substrates is affected by the presence of EA via the EutVW two-





Chapter 2: Discovery of a riboswitch-containing sRNA that 
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2.2 Introduction 
During the last decade there has been dramatically increased recognition that 
RNAs can serve many types of regulatory roles, and not simply as a passive 
intermediate between DNA and protein. Regulation at the RNA level is important in 
all three kingdoms of life, and a variety of regulatory RNAs and their mechanisms of 
action have been identified. Riboswitches are one such important class of RNA-based 




regulatory components located primarily in the 5' untranslated regions of mRNAs; 
however, they can also be found in the 3' untranslated regions of mRNAs or within 
intercistronic regions of transcripts. They comprise an aptamer domain that directly 
interacts with a target ligand, and a downstream expression platform, which 
undergoes structural changes upon ligand binding to influence gene expression. The 
earliest studies on riboswitches described expression platforms controlling 
transcription termination via rho-independent terminator/antiterminator structures, or 
the start of translation by controlling access to a RBS (71). However, more recently, 
additional mechanisms have been documented, such as the signal-responsive control 
of mRNA cleavage and degradation by riboswitches (64, 65). Additionally, the role 
of riboswitches in termination was recently expanded to include rho-dependent 
termination (117).  
In addition to riboswitches, bacteria also frequently employ trans-acting 
noncoding RNAs (sRNAs) for posttranscriptional genetic regulation (9, 118, 119). 
sRNAs typically regulate gene expression by forming short, interrupted base-pairing 
interactions with target mRNAs, to affect translation or mRNA stability (2). 
However, a few sRNAs have been shown to affect gene expression patterns by 
instead sequestering RNA-binding proteins. For example, CsrB and CsrC are E. coli 
sRNAs that feature a tandem collection of binding sites to sequester the important 
regulatory protein CsrA, which is involved in catabolite repression (4). CsrA is an 
RNA-binding protein that affects expression of many mRNAs; consequently, the 
CsrB/C sRNAs affect global gene expression by titrating CsrA from its mRNA 




bacteria appear to encode for CsrA or proteins that are reasonably closely related to 
CsrA (4, 34). For example, in Pseudomonas species, RsmA, a translational repressor 
protein, belonging to the CsrA family, binds GGA motifs present in the leader of 
target mRNAs (120). The location of the GGA motif often coincides with the Shine 
Dalgarno sequence, thus RsmA can obstruct translation initiation. In Pseudomonas 
aeruginosa the function of RsmA is regulated by two functionally redundant sRNAs, 
RsmY and RsmZ. Lastly, in several bacterial plasmids regulation of RepA synthesis 
is controlled by an asRNA, CopA. CopA interacts with its target, CopT, an asRNA in 
the RepA mRNA transcript, which results in the formation of an RNA-RNA duplex, 
demonstrating an additional form of posttranscriptional regulation by RNA-mediated 
sequestration (121).  
Interestingly, some recently discovered genetic regulatory mechanisms challenge 
the traditional perceptions on riboswitch regulation, and blur the lines between simple 
classification of “cis” and “trans” regulatory RNAs. For instance, two examples were 
discovered where riboswitches affected gene expression in trans, rather than, or in 
addition to, the cis-acting regulatory functions that are generally presumed to occur 
(122). This was previously demonstrated for a Listeria monocytogenes S-
adenosylmethionine (SAM)-responsive riboswitch, which, although it functions as a 
classical cis-acting riboswitch, was also discovered to act in trans to form Watson-
Crick base pairing interactions with the 5' leader region of a target mRNA. Upon 
associating with the target mRNA, it was found to decrease translation, analogous to 
the function of traditional sRNAs (122).    




initiation mechanisms of gene regulation in the EA utilization (eut) locus of E. 
faecalis for several years. This locus encodes the genes required for the breakdown of 
EA.  In Salmonella species, the eut locus is activated by a DNA-binding transcription 
factor, EutR, in response to two signals – EA and AdoCbl (77, 83, 84, 100). In 
Enterococcus, Clostridium and Listeria species, the eut locus contains in place of 
EutR a two-component regulatory system: EutW histidine kinase and EutV response 
regulator. EutVW is important for promoting microcompartment formation in E. 
faecalis, as can be seen in figure 2-1B when deletion of EutVW, even in the presence 
of AdoCbl and EA, prevents microcompartment formation.  
 Discovery of the EutVW TCS accounts for how E. faecalis couples detection 
of EA to genetic regulation of the large eut gene cluster. However, if E. faecalis relies 
upon the same signals for genetic regulation of EA utilization microcompartments as 
Salmonella, it should also incorporate a mechanism for sensing AdoCbl (83). Indeed, 
our prior data suggested that in vivo expression of the E. faecalis eut genes requires 
AdoCbl in addition to EA (Figure 2-1A) (113). This is also true for the formation of 
Eut microcompartments (Figure 2-1B). Therefore, we hypothesized that E. faecalis, 
and by extension other eut-containing bacteria, regulate EA catabolism in a manner 
that is sensitive to the presence of AdoCbl.  
Riboswitches that sense AdoCbl have been previously described (62, 123). To 
examine whether a riboswitch could account for AdoCbl regulation of E. faecalis eut 
genes, the Winkler and Garsin laboratories specifically examined the intergenic 
regions within the eut gene cluster for evidence of secondary structure and primary 











Figure 2-1. EA and AdoCbl induce eut gene expression and microcompartment formation. (A) 
RNA-seq showed that eut genes were expressed in the presence of EA and AdoCbl, whereas little or 
no expression was observed in modified minimal media. (B) Shown are representative cells observed 
by TEM. The wild type cells (OG1RF) grown in EA and AdoCbl contained microcompartments, while 
the eutVW cells, containing a deletion of the two-component system, and/or without both inducing 
compounds, had none. The light grey, icosahedral-like structures within the cells are indicative of these 









located between eutT and eutG was identified through these efforts based on 
secondary structure conservation. Of specific interest, this RNA element exhibited 
high similarity to an AdoCbl-sensing riboswitch class described previously (83, 124–
126). Also, a sequence motif closely resembling the putative E. facaelis eutT-G 
AdoCbl riboswitch could also be identified in the eut operon of Listeria species. 
The aptamer portion of the putative E. facaelis eutT-G AdoCbl riboswitch was 
then investigated by in-line probing (113), which is a secondary structure probing 
method (127). This revealed that only a small portion of the eutT-G intergenic region 
appeared to exhibit a significant degree of secondary structure content. Analysis of 
truncated sequences then narrowed this region to ~200 nt, which included a putative 
AdoCbl riboswitch. In-line probing was again used to investigate the secondary 
structural arrangement of the eutT-G riboswitch upon varying AdoCbl concentrations. 
The addition of AdoCbl resulted in decreased band intensity at a number of different 
RNA positions, suggesting that AdoCbl bound to the RNA. These data suggested that 
AdoCbl induces a global conformational change for the eutT-G riboswitch with an 
apparent Kd of ~ 540 nM, which is comparable with the dissociate constants for the 
canonical AdoCbl riboswitch (126). However, the apparent Kd for an AdoCbl analog, 
cyanocobalamin, was significantly poorer, demonstrating that the eutT-G riboswitch 
is selective for AdoCbl.  
Classical AdoCbl riboswitches promote premature transcription termination in 
5' leader regions in response to binding of AdoCbl. Such a role would not be logical 
for the eutT-G AdoCbl riboswitch; it would not make sense for the riboswitch to 




the opposite. Therefore, at the onset of this project it was unclear how the putative 
AdoCbl riboswitch affected eut gene expression in E. faecalis, as well as other eut-
expressing Gram-positive bacteria. In this chapter, I sought to answer this challenging 
question.  
2.3 Results and Discussion 
2.3.3 Detection of transcripts produced within the E. faecalis eutT-G 
intergenic region 
 Previously a constitutive promoter was detected upstream of the AdoCbl 
riboswitch located in the upstream portion of the eutT-G intergenic region (112). 
However, a second promoter was also predicted and experimentally verified upstream 
of eutG (112, 113). The discovery of two active promoter DNA sequences within a 
single intergenic region (eutT-eutG) was unexpected, and suggested strongly that the 
AdoCbl riboswitch may be involved in a regulatory mechanism other than simple 
attenuation control of eutG, as would be predicted for traditional riboswitches. 
Therefore, we sought to investigate the transcriptional landscape of this region and to 
begin to explore the regulatory function of the putative eutT-eutG AdoCbl riboswitch.  
 The first question to explore was whether a transcript encompassing the 
putative AdoCbl riboswitch could be detected, either as the result of premature 
termination within a long eutG leader region or as part of an independent noncoding 
RNA transcript. To that end, total RNA from E. faecalis OG1RF was extracted from 
cells grown in modified minimal medium in the presence or absence of EA and/or 
AdoCbl. The RNA was resolved by denaturing polyacrylamide gel electrophoresis 






Figure 2-2. Northern blot analysis of the eutT-eutG intergenic region shows two RNA species. (A) 
Location of the 32P-radiolabeled DNA oligonucleotide probes used to analyze the eutT-eutG intergenic 
region. (B) Total RNA was isolated from cells grown in the indicated medium conditions, resolved by 
denaturing polyacrylamide gel electrophoresis, transferred to a membrane, and hybridized with 


































membranes were then probed with 5'-radiolabeled DNA oligonucleotides. 
Specifically, the JRG174 oligonucleotide corresponded to the 3' end of the intergenic 
region, and JRG175 corresponded to the 3' portion of the AdoCbl riboswitch (Figure 
2-2A).  
 DNA probe JRG174 indicated a faint band present for cells grown in the 
absence of EA and AdoCbl, but a slightly more intense band of the same size when 
cells were grown in the presence of only EA (Figure 2-2B). Upon reprobing the 
northern blot with DNA probe JRG175, the two previously mentioned bands 
exhibited greater signal intensity, but the blots also showed multiple faint bands of 
smaller sizes, found only for cells cultured in the presence of AdoCbl, regardless of 
the presence of absence or EA (Figure 2-2B). The simplest interpretation of these data 
was that two RNA species were being produced: one was present in low levels in 
minimal media and induced in the presence of EA, and the second, smaller species, 
was present only when AdoCbl was supplemented to the media. However, these 
northern blots were not entirely convincing by themselves, due to the lack of overall 
intensity of each band. Due to the lack of sensitivity, we turned to internally 
radiolabeled antisense RNA probes in the hopes of increased sensitivity to these two 
RNA species. Indeed, probing northern blot membranes with a radiolabeled RNA that 
corresponded to the antisense sequence of the ~370 nucleotide eutT-eutG intergenic 
region revealed much higher band intensity signals (Figure 2-3). However, the overall 
pattern of bands remained the same. Therefore, the combination of RNA probes 
revealed that E. faecalis was likely to produce two RNA species of differing lengths, 




   
 
 
Figure 2-3. Northern blot analysis of the eutT-eutG IGR. (A) Location of the 32P-radiolabeled RNA 
antisense probes used to analyze the eutT-eutG intergenic region. (B) Total RNA was isolated from 
cells grown in the indicated medium conditions, resolved by denaturing polyacrylamide gel 




































 In order to determine the approximate sizes of these RNA species, an RNA 
size standard was resolved alongside total RNA aliquots by denaturing 
polyacrylamide gel electrophoresis and subjected to northern blot analyses. Total 
RNA from the four primary growth conditions (minimal media, plus AdoCbl, plus 
EA, and plus AdoCbl/EA) were analyzed thusly. The distance that each RNA species 
of the RNA size ladder traveled relative to the well was plotted as part of a size 
standard curve (Figure 2-2C). By comparing the RNA species that were identified for 
cells cultured in the presence of AdoCbl to the size standard curve, they were 
estimated to correspond to a length of approximately 150 nucleotides. However, the 
larger species, present at low levels in minimal media, and induced by cells grown in 
the presence of EA, was approximately 300 nucleotides in length.  
 The discovery of two active promoter DNA sequences within the single 
intergenic region of eutT-eutG was generally unexpected. Nevertheless, we initially 
hypothesized that the AdoCbl riboswitch found within the eutT-eutG intergenic 
region may participate in a regulatory mechanism, such as attenuation control of 
eutG, as would be expected for traditional riboswitches. However, northern blot 
analyses of this intergenic region, first using DNA oligonucleotide probes, and 
second, using higher sensitivity RNA antisense probes, suggested instead that there 
were two RNA species produced from this intergenic region. This intriguing 
observation suggested that the AdoCbl riboswitch was not simply involved in 
attenuation control of eutG through use of a classical riboswitch regulatory 




complex or unusual.  
2.3.3 Sequence analysis of the eutT-G intergenic region reveals a new putative 
ANTAR substrate 
 Our northern blot analyses had revealed the presence of two transcripts of 
different sizes; however, it did not determine to which portions of the eutT-eutG 
intergenic region they corresponded. To help resolve this question, the membranes 
were hybridized with internally radiolabeled RNA probes, which were designed to 
anneal to different regions (Figure 2-3A). Probes that were designed to specifically 
anneal to the AdoCbl riboswitch resulted in bands corresponding to both the ~150mer 
and ~300mer RNAs (Figure 2-3B, purple). This suggested that the riboswitch was 
included in both of the eutT-eutG intergenic transcripts. From these aggregate data, 
we concluded that an sRNA of approximately ~300 nucleotides and that includes the 
AdoCbl riboswitch is produced from the eutT-eutG intergenic region. We named the 
noncoding RNA EutX. These data also suggested that a shortened version of EutX, 
which also includes the AdoCbl riboswitch, is produced when cells are cultured in 
media that includes AdoCbl.  
 Manual inspection of the sequences downstream of the AdoCbl riboswitch 
surprisingly revealed the presence of a putative two-hairpin motif, which is 
remarkably similar to the EutV transcription attenuation substrates found elsewhere in 
the eut gene cluster. Specifically, it was found that there are two hairpins 
approximately 114 nucleotides downstream of the riboswitch, which are separated by 
7 nucleotides and contain the core conserved residues found in other ANTAR 




attenuation sites, this particular two-hairpin motif, which was termed P3P4, did not 
appear to overlap with an adjacent intrinsic terminator site, suggesting it might have a 
function other than classical transcription attenuation. To investigate whether these 
hairpins were included as part of the newly discovered EutX RNA, an antisense probe 
that included this sequence was utilized in northern blot analyses. The short form of 
EutX (~150 nt) was not observed on these blots, whereas the long form (~300 nt) 
could be readily observed (Figure 2-3B, blue). Therefore, we conclude from these 
data that the shortened form of the EutX transcript is likely to be comprised largely of 
the AdoCbl riboswitch, whereas the longer form of EutX also includes the riboswitch 
but extends beyond it to include the newly identified P3P4 hairpin motifs.  
2.3.3 Determination of termini of EutX RNAs 
 To identify the termini of the short and long forms of EutX, we employed 
rapid amplification of cDNA ends (RACE) with circularization. We isolated RNA 
from cells grown in the presence of EA without AdoCbl, since these cells lacked the 
shortened form of EutX. Total RNA was treated with DNase I to remove 
contaminating DNA and with Terminator exonuclease, which exhibits specificity for 
5' monophosphorylated transcripts and is oftentimes used to remove ribosomal RNA. 
The Terminator exonuclease-treated RNA was then incubated with Tobacco Acid 
Pyrophosphatase to convert 5'-triphosphates to 5'-monophosphates. The RNA was 
then incubated under dilute conditions with T4 RNA ligase, in order to encourage 
intramolecular circularization. After cDNA synthesis and PCR amplification, the 
amplified DNA was sub-cloned into an appropriate vector. Sequencing analyses were 










Figure 2-4. Analysis of EutX termini.  5' RACE (circularized) mapped 8 sequences to the 5' site 
AAUUA in the presence of AdoCbl and EA (red triangle). 3' RACE (circularized and linear) mapped 8 
sequences to the 3' termini at U153, in the presence of AdoCbl alone, the same size indicated by 
northern blot (green triangle). 3' RACE (linear) mapped 8 sequences to the oligouridate tract 3' of the 
P4 stem-loop, in the presence of EA alone, the same size indicated by northern blot (pink triangle). The 









 Of eight sequences that were obtained from this analysis, all exhibited the 
same apparent 5' terminus. Specifically, the sequences all began at the same A 
residue, located shortly after the promoter upstream of the riboswitch (Figure 2-4, 
red triangle). This method also allows for simultaneous identification of the 3' 
terminus. Of these same eight sequences, all exhibited a 3' terminus located at the end 
of an oligouridylate tract that occurs just upstream of the -35 of the downstream eutG 
promoter (Figure 2-4, pink triangle) and just downstream of P3P4. Since 
oligouridylate tracts are usually positioned at the ends of intrinsic terminator sites, we 
examined the sequence surrounding P3P4, but could find no convincing helical 
element that could be construed as being part of an intrinsic terminator site. Also, the  
distance between the 5' and 3' termini, as mapped by this study, was approximately 
300 nucleotides, which corroborates well with the results of the size estimation of 
EutX described above.  
 We also attempted a complementary approach identifying the termini of EutX 
RNAs for cells cultured in the absence of AdoCbl and presence of EA. We employed 
an altered 3' RACE procedure where RNA molecules were ligated to a 5' pre-
adenylated linker (NEB, Universal miRNA cloning linker), which could be used for 
subsequent cDNA amplification, PCR amplification, sub-cloning and DNA 
sequencing. This treatment and analysis revealed that culture conditions that include 
high amounts of EA, but low amounts of AdoCbl, resulted in 3' termini within an 
oligouridylate tract after P3P4 (Figure 2-4, pink triangle). The sequencing data again 
demonstrated that 3' termini form at one of several sites at the end of the 




the second U, two sequences corresponding to termini in the third U, and finally four 
sequences corresponding to the fourth U of the polyU tract found just downstream of 
the second hairpin, P4, in the two-hairpin motif. This suggests that EutX overall is 
between 296 and 298 nucleotides in length. Again, this confirmed our predicted size 
of ~300 nucleotides of the RNA induced in the presence of EA.   
 The same method was used to determine the 3' termini of the shortened form 
of EutX, which was observed for cells grown in the presence of AdoCbl but absence 
of EA. This treatment and analysis revealed a 3' terminus at the end of the riboswitch 
aptamer where another stretch of U residues can be found (Figure 2-4, green 
triangles). Given the 5' terminus we previously identified, the total length of this RNA 
sequence would be 150 nucleotides, which agrees well with the results of the northern 
blot analyses. Upon further investigation, the poly U tract sequence appeared to be 
part of an intrinsic terminator hairpin, which is formed from sequences at the 3' end 
of the AdoCbl riboswitch aptamer (Figure 2-4, grey box). This observation strongly 
suggests that a riboswitch-associated intrinsic terminator site is formed under 
conditions of high AdoCbl or in the presence of AdoCbl, but absence of EA. This is 
in contrast to previous studies, which suggested the AdoCbl-sensing element was 
involved in transcription antitermination (113). 
2.3.4 Deletion analysis of EutX 
 We postulated that the P3P4 ANTAR substrate located 3' of the AdoCbl 
riboswitch, which is not transcribed in the presence of AdoCbl, should not affect 
transcription of the AdoCbl riboswitch itself. To test our hypothesis, we extracted 




P3P4, or both the riboswitch and P3P4. The RNA was then resolved by denaturing 
polyacrylamide gel electrophoresis, and transferred to a positively charged membrane 
for northern blot analyses. These membranes were probed with radiolabeled DNA 
oligonucleotides JRG174 and JRG175. As expected when both the riboswitch and 
P3P4 element were deleted, neither DNA probe was able to detect a band (Figure 2-5, 
right). Probing the deletion of just the riboswitch, which should leave P3P4 unaltered, 
showed that indeed the riboswitch was undetected. However, deletion of the 
riboswitch prevented detection of P3P4 (Figure 2-5, left). We speculate that this may 
be due to instability of the RNA transcript in the absence of the 5' AdoCbl riboswitch. 
When we probed the deletion of P3P4, we, as expected, lost the ability to detect P3P4 
by JRG174. However, this deletion also affected the detection of the AdoCbl 
riboswitch. Instead of seeing the EutX 150mer in the presence of AdoCbl and 
AdoCbl/EA, we saw the 150mer product present in minimal media alone and 
AdoCbl, but not in the presence of AdoCbl/EA (Figure 2-5, middle).  
2.3.5 The EutX AdoCbl riboswitch can terminate transcription in vitro 
 The in vivo evidence demonstrated that the EutX AdoCbl riboswitch promotes 
formation of a 150mer RNA product when cells are cultured in the presence of 
AdoCbl. This suggested that the riboswitch is likely to promote premature 
transcription termination in response to binding of AdoCbl. To test this hypothesis, 
we utilized a single-round synchronized transcription termination assay (128). We 
designed a PCR-generated, double-stranded DNA template for transcription of the 






Figure 2-5. Northern blot analysis of deletion strains. Total RNA was isolated from cells grown in 
the indicated conditions, resolved by denaturing polyacrylamide gel electrophoresis, transferred to a 
membrane, and hybridized with different DNA oligonucleotide probes. Left corresponds to a strain 
with a deletion of the AdoCbl riboswitch; middle, deletion of the P3P4 element; right, deletion of both 














































from +5 to +170 of EutX sequence, was nucleotides -135 to +1 of the B. subtilis 
glyQS promoter. The DNA template also included 20 nucleotides that follow the 
putative EutX riboswitch intrinsic terminator. We hypothesized that the presence of 
this additional sequence at the 3' end would permit us to quantitatively measure 
transcripts resulting from “run-off” versus “premature termination”, by denaturing 
polyacrylamide gel electrophoresis.  
 The DNA template was designed such that it lacked cytidine residues until 
position +30, relative to the transcription start site. By omitting CTP from an 
initiating mixture of NTPs, the transcription elongation complex was therefore halted 
at position 29 (Figure 2-6A, highlighted in red). To release the elongation complexes 
from the halt site, all four NTPs were added. Heparin was simultaneously added for 
prevention of reinitiation. Synchronizing transcription elongation complexes in this 
manner increases the overall sensitivity of the assay and prevents cooperative effects 
that emerge from the presence of multiple polymerase complexes on the same DNA 
template (129). 
 This assay revealed the presence of two prominent bands in the presence of 
AdoCbl that could be resolved by 6% denaturing PAGE (Figure 2-6B, WT). A 
template ending at the predicted terminator site, +150 nt as a size standard for 
“termination”. Additionally, a template with an extra 20 nucleotides, +170 nt, added 
downstream of the predicted terminator site was used as a size standard for “run-off”. 
The longer product was interpreted to result from run-off transcription on the DNA 
template since it ran alongside our +170 nt size standard. The shorter RNA product 





Figure 2-6. AdoCbl binding to the riboswitch causes premature termination. (A) Schematic 
showing the secondary structure of the AdoCbl riboswitch in EutX. A putative intrinsic terminator is 
highlighted in a grey-shaded box. The red nucleotides denote the halted complex for the single-round 
transcription. Mutation to the L5 loop, M3, shown in blue. (B) In vitro transcription termination assay 
with wild-type EutX template displays a premature termination product only in the presence of 
AdoCbl. In vitro transcription termination assay with M3 EutX template displays that termination is 





















































































































































































































the +150 nt “termination” standard. Under these assay conditions and no AdoCbl and 
the absence or presence of EA, approximately 92.7% and 97.1%, respectively, of 
transcription corresponded to full-length transcripts, which we hypothesize requires 
readthrough of the riboswitch intrinsic terminator site. In support of this, addition of 
250 µM AdoCbl resulted in a significant increase in the prematurely terminated 
product, reducing terminator readthrough to ~60%. However, while these data 
support our hypothesis that the AdoCbl riboswitch promotes transcription termination 
in an AdoCbl-dependent manner, it is important to note that the readthrough 
frequency is likely to be very different in vivo, where the cell experiences different 
ionic conditions, NTP concentrations and the presence of transcription elongation 
factors that are absent in our biochemical assay. Therefore, we conclude that the 
transcription termination assay provides important proof-of-principle demonstration 
that the EutX riboswitch promotes termination in response to AdoCbl. 
 To test our hypothesis on the riboswitch further, we chose to introduce a 
mutation that would be predicted to result in a loss of AdoCbl binding. To identify an 
appropriate mutation, we considered canonical AdoCbl riboswitches. The secondary 
structure of canonical AdoCbl riboswitches includes a small loop, which contains 
three highly conserved cytosines that form a pseudoknot with downstream guanosines 
(39). The formation of this pseudoknot is necessary for ligand binding (123). The 
EutX AdoCbl riboswitch is predicted to contain this same characteristic stem-loop, 
which has been described as L5 (Figure 2-6A, blue). We then mutated these three 
residues to guanines and found that the mutant sequence led to an increase in run-off 




AdoCbl (Figure 2-6B, M3).  
2.3.6 The EutX P3P4 site is required for genetic regulation of the eut gene cluster 
 EA was previously shown to activate autophosphorylation of EutW and the 
subsequent phosphoryl transfer between EutW and EutV, resulting in dimerization of 
EutV causing an overall increase in EutV RNA-binding affinity (111–114). 
Identification of the additional two-hairpin motif in the eut gene cluster, P3P4, led us 
to hypothesize that EutV binds EutX at this site. To further characterize the function 
of EutX and this putative ANTAR substrate, P3P4, the ability to bind EutV was 
examined by electrophoretic mobility assays (EMSAs) and differential radial 
capillary action of ligand assays (DRaCALA) (130). Upon addition of micromolar 
concentrations, purified EutV bound to a portion of EutX that contained P3P4 in vitro 
(Figure2-7A and B) much like it binds the first two-hairpin substrate in the eut 
operon, P1P2 (Figure2-7C and D). Unlabeled 30 µM competitor RNA (EutX or 
P1P2) could fully compete for binding to EutV in the context of radiolabeled EutX or 
P1P2 (Figure 2-7A and C second to last lane). However, an unrelated RNA of similar 
length was unable to compete for EutV, which demonstrated that binding of EutV to 
EutX is specific (Figure2-7A and C last lane).  
 However, to determine whether the EutV-EutX interaction is functionally 
significant in vivo, we sought to gain further genetic evidence for this hypothesis. We 
generated a eutG-lacZ fusion that contained the entire intergenic region between eutT 
and eutG (Figure 2-8A). We transformed this construct into E. faecalis strain SD289, 









Figure 2-7. EutV specifically binds EutX. (A) EMSAs were used to analyze binding of EutV to 
EutX. A 117 nt fragment of EutX (‘117EutX’), and EutVD54E protein were utilized (constitutively 
active for RNA binding). Controls included addition of 30 µM of an unlabeled competitor EutX RNA 
and a completely unrelated RNA. (B) Differential radial capillary action of ligand assay (DRaCALA) 
was used to assess EutV binding to 117EutX. (C) EMSAs were used to investigate whether EutX could 
compete for EutV binding to P1P2, and EutVD54E protein. Controls included addition of 30 µM of an 
unlabeled competitor EutX RNA and a completely unrelated RNA. (D) Differential radial capillary 
action of ligand assay (DRaCALA) was used to assess EutV binding to the P1P2 RNA using the same 


































Figure 2-8. EutX acts in trans to sequester EutV. (A) A diagram of the experimental design. A 
plasmid containing a eutG-lacZ fusion was manipulated to contain a deletion of the riboswitch, the 
P3P4 hairpin, or both. The plasmid was introduced into E. faecalis strains containing either wild type 
EutX or a deletion. (B). β-galactosidase assays of strains shown in (A) when grown in modified 
minimal medium containing EA or both EA and AdoCbl. (C) Schematic of M1, M2, and M3 
mutations. (D). β-galactosidase assays of strains missing EutX but carrying eutG-lacZ plasmids that 
contain either the M1 or M2 or M3 mutations. M1 mutation contains A249U and G252U site-directed 
changes. M2 mutation contains A273U and G276U site-directed changes. These mutations alter the 
conserved 1st and 4th positions within the P3 and P4 terminal loops. M3 mutation contains G58-60C. 
The data presented in (B) and (D) is the average of three or more independent experiments and the 






Using this background was necessary for accurate analysis of mutations in the eutG-
lacZ construct; if EutX functions to sequester active EutV~P, this activity would be 
predicted to affect gene regulation in trans. As shown in Figure 2-8B (dashed blue 
bars), expression of wild-type eutG-lacZ was induced by the presence of EA and 
AdoCbl when cells were grown in a modified minimal medium. These requirements 
for eut gene expression were previously reported by another group using a similar 
eutG-lacZ construct (112), and by our own studies employing lacZ fusions to 
different eut genes (114). Next, a construct with a deletion for the putative P3P4 
ANTAR substrate was tested. Surprisingly, this construct was induced to very high 
levels, just by adding EA (Figure 2-8B, dashed green bars). Though the riboswitch 
aptamer was still present, the requirement for AdoCbl was completely relieved. 
Additionally, deleting the riboswitch aptamer had no further effect on expression 
(Figure 2-8B, dashed orange bars). These data are consistent with the hypothesis that 
the P3P4 two-hairpin motif of EutX sequesters active EutV~P; when P3P4 is not 
present, however, EutV~P is not sequestered and can activate eut gene expression by 
its antitermination activity at the other ANTAR substrates in eut gene cluster. We 
postulate that the riboswitch’s function is to prevent protein sequestration when it is 
bound to AdoCbl. As predicted by this model, a construct in which the riboswitch 
aptamer of EutX was deleted, but still contained P3P4, was not induced under any 
condition, even when both AdoCbl and EA were added to the medium (Figure 2-8B, 
dashed red bars). When a wild type strain containing the endogenous locus of EutX 




both AdoCbl and EA were present (Figure 2-8B, solid green and orange bars relative 
to striped bars). Because the regulation of the lacZ constructs can be altered by the 
presence or absence of EutX in the chromosome, these data suggest that the sRNA 
can regulate in trans and are consistent with the a sequestration model (Figure 2-9).  
 The deletion mutants tested in Figure 2-8B removed significant amounts of 
primary sequence in the eutT-eutG intergenic region. These large disturbances could 
effect eutG gene regulation by mechanisms other than what we propose. To 
ameliorate this concern and further test the sequestration model, we made targeted 
point mutations in the eutG-lacZ construct (Figure 2-8C). For example, the sequence 
of the six-nucleotide loops of the ANTAR dual hairpin substrates was previously 
shown to be important for effective binding by ANTAR protein. In particular, an 
adenosine (A) at the first position and a guanine (G) at the fourth position were 
required (114). The putative P3P4 substrate also contains A’s at the first position and 
G’s at the fourth position of the loops (Figure 2-8C). We tested one mutant, in which 
the A1 and G4 of the P3 loop were mutated to U’s (Mut1) and a second mutant in 
which the P4 loop contained these same mutations (Mut2). The strains containing the 
Mut1 and Mut2 point mutations, respectively, were both induced by EA alone, in 
contrast to the wild-type eutG-lacZ construct (Figure2-8D, black solid bars relative to 
dashed bars). Since these mutations are predicted to prevent EutV from binding to the 
putative P3P4 sequestration substrate, the results were as predicted.   
 Recent structural work on AdoCbl riboswitches has confirmed the importance 
of the L5 loop of the ligand-bound aptamer (113). L5 is characterized by three 




form a pocket that enables AdoCbl binding. The eut AdoCbl riboswitch is predicted 
to contain this characteristic L5 loop (Figure 2-8C, highlighted in blue) (113), thus we 
mutated the three cytosines to guanines to create Mut3. Like complete deletion of the 
riboswitch, this resulted in a lacZ construct that was not inducible (Figure 2-8D, M3 
black and dashed bars). 
2.4 Conclusion 
 Bacteria must be able to sense their environment and respond readily to any 
environmental stimuli or changes, including from within the GI-tract, where 
microbial inhabitants are typically required to exhibit metabolic flexibility. Since one 
of the nutritional options for GI-tract microbes is EA, it is reasonable that the gut 
commensal E. faecalis synthesizes the eut gene cluster for EA utilization. Through 
our studies on eut genes, we have now discovered multiple genetic regulatory 
mechanisms that affect their expression. Previously, we found that the sensor kinase, 
EutW, directly senses EA to promote autophosphorylation and then phosphoryl-
transfer to activate the response regulator, EutV, which through its RNA-binding 
ANTAR domain activates readthrough of several transcription terminator sites 
permitting downstream eut transcription. However, in this study, we discovered that 
E. facaelis, like Salmonella species, also incorporates sensing of AdoCbl for genetic 
regulation of eut genes. In contrast to the transcription factor EutR for Salmonella 
species, E. faecalis employs an AdoCbl-sensing riboswitch. The AdoCbl-riboswitch 
in E. faecalis is unique in that it is part of a trans-acting RNA element, EutX. The 
two-hairpin motif present in EutX, P3P4, is responsible for the binding and 











Figure 2-9. Model of the regulation of the eut gene cluster by EutX. Model for how EutX uses both 

















AdoCbl is not, EutV~P will be bound to EutX, preventing antitermination at the other 
sites within the eut gene cluster, thus shutting down eut gene expression (Figure 2-9, 
top right). However, if AdoCbl is present, the free and active EutV~P is available to 
antiterminate and promote eut gene expression (Figure 2-9, bottom right).  
 Sequestration of EutV by EutX makes logical sense since it would prevent the 
overproduction of accessory eut genes, which are presumably energetically taxing, 
and wasteful when the primary cofactor for EA catabolism is limited.  However, 
several questions remain to be answered. It is not understood what the affinity of 
EutV for EutX is, or more simply the affinity for P3P4. Understanding the affinity of 
EutV for P3P4 combined with an understanding of the relative concentrations of 
EutV, EutX, and the AdoCbl riboswitch in vivo would greatly aid in the 
understanding of this regulatory circuit, and its biological relevance. The 
sequestration of EutV by EutX could be as simple as a much higher concentration of 
EutX relative to EutV in the absence of AdoCbl, thus EutX would be acting as a 
sponge for EutV. Alternatively, in conditions where there is limited AdoCbl, EutX 
could merely have higher affinity for EutV than the other ANTAR substrates present 
in the eut gene cluster. Understanding the biophysical interactions between the 
ANTAR domain of EutV relative to the ANTAR substrates would shed light on other 
ANTAR-domain containing proteins. Much has been characterized in terms of the 
RNA side of the binding requirements for antitermination in vitro, however, little is 
understood about the protein side. Further understanding of the direct RNA-protein 
interactions is needed to better understand the sequestration of EutV by EutX.  




regulatory RNA. However, this sRNA is particularly novel in that it also contains an 
AdoCbl-binding riboswitch that regulates in-cis the protein-sequestration activity. 
This discovery therefore presents a new type of protein-sequestering sRNA as well as 
a novel mechanism for riboswitch action.  In Figure 2-10 we see the current modes of 
riboswitch action, where they have been shown to function in transcription 
termination/antitermination (Figure2-10 A), translation inhibition (Figure 2-10 B), 
and affecting mRNA stability (Figure 2-10 C), but now we have identified a 
riboswitch that controls the formation of a two-hairpin motif, responsible for protein 
sequestration, and downstream gene expression (Figure 2-10 D). Not only is this a 
new mechanism for riboswitch action, it is not the only one of its kind. Shortly after 
identification of the E. faecalis EutX, a similar riboswitch-containing sRNA, Rli55, in 
L. monocytogenes was discovered suggesting this may be conserved in bacteria that 












Figure 2-10. Updated summary of different modes of action for cis-acting RNAs. (A) Control of 
formation of an intrinsic transcription terminator by a metabolite-binding riboswitch, ‘M’ denotes the 
metabolite ligand. (B) Control of translation initiation efficiency by a metabolite-sensing riboswitch. 
(C) Control of mRNA stability by conformational change of a riboswitch upon binding its ligand. (D) 






Chapter 3: Antitermination determinants of the Enterococcus 
faecalis ethanolamine-responsive two component regulatory 
system 
 
3.1 Author contribution 
Data gathered by Gebbie, M. are in Figs 3-1 through 3-16, while data gathered 
by Weiss, C.A., are in Fig. 3-3B. 
 
3.2 Introduction 
 The ability to sense and respond to sudden changes within an environmental 
niche is essential for all microorganisms. Correspondingly, microorganisms have 
evolved many genetic regulatory strategies for coupling specific recognition of 
cellular changes to control of gene expression. One of the most universal bacterial 
strategies for coordinating signals with cellular adaptations is through the use of two-
component regulatory systems (TCS) (133). In the typical TCS, a sensor kinase 
protein perceives a chemical or physical signaling cue and couples this information to 
autophosphorylation of a conserved histidine (133). Autophosphorylation then 
promotes transfer of the phosphoryl group to an aspartate located within a highly 
conserved receiver domain of the cognate response regulator protein. Phosphoryl 
transfer to the response regulator protein triggers changes to an output domain, which 
can affect protein:protein interactions, enzymatic activity, or gene expression (134). 
A majority of these signal transduction pathways rely on DNA-binding output 




However, an increasing number of RNA-mediated mechanisms have been identified 
that can affect gene expression at the post-initiation level (2, 3). In recent years our 
laboratory, as well as other laboratories, have found that a subset of these post-
initiation regulatory mechanisms utilize TCS for coupling signal detection to post-
initiation regulatory control (131, 132).  
To exert post-initiation regulatory control, some TCS incorporate an RNA-
binding output domain into the response regulatory protein. A characteristic domain 
called the AmiR and NasR Transcriptional Antiterminator Regulator domain 
(ANTAR) is used in these instances (106, 108, 113, 114, 135, 136). Approximately 
1% of TCS appear to utilize RNA-binding ANTAR domains (134, 137); however, 
ANTAR domains can also be found widespread in other protein architectures (106). 
Sequence homology-based searches have predicted more than 1100 ANTAR domain-
containing proteins, widely distributed across at least 644 bacterial species (114). 
ANTAR-domains are usually found within multi-domain proteins. The largest class 
of ANTAR-containing proteins, comprising nearly 50%, consists of ANTAR-based 
response regulators; however, several other arrangements are common. One 
important class of ANTAR proteins seem to possess an N-terminal pseudo-receiver 
domain capable of protein-protein interactions (137). This class of ANTAR protein, 
therefore, may regulate gene expression via interactions with a modulator protein that 
itself may possess signal-sensing function. For example, the Pseuodomonas 
aeruginosa ANTAR protein, AmiR, dimerizes upon binding two molecules of its 
negative regulator AmiC (108, 137). Under inducing conditions, AmiC binds a small 




associate with the 5' leader of its target gene. Binding of AmiR to the nascent 
transcript prevents formation of an intrinsic terminator site and instead permits 
transcription elongation of downstream portions of the transcript. The ANTAR 
domain also occurs in conjunction with a diverse set of signal-sensing domains. For 
example, in Klebsiella oxytoca, NasR contains a nitrate and nitrite-sensing (NIT) 
domain fused to an ANTAR domain and regulates the nasFEDCBA operon (107, 
115). In the presence of nitrate, NasR is activated to bind to the 5' leader region of the 
nascent nasF transcript. Similar to AmiR, association of NasR inhibits formation of 
an intrinsic terminator within the 5' leader region, thereby allowing synthesis of the 
downstream nas operon. However, while these prior data demonstrated that both 
AmiR and NasR are RNA-binding proteins, that prevent formation of an intrinsic 
terminator, the determinants for RNA-binding remained unidentified.  
 E. faecalis EutV, much like AmiR and NasR, contains an ANTAR domain at 
its C-terminus that associates with RNA to prevent formation of intrinsic terminators, 
allowing for downstream expression of the eut gene cluster (113, 114). EutV is also 
conserved in other Firmicutes that contain eut gene clusters, and is likely to 
participate in common regulatory mechanisms (72, 111, 113). For E. faecalis, the 
corresponding sensor kinase, EutW, undergoes autophosphorylation upon sensing 
ethanolamine, which correspondingly triggers phosphorylation and dimerization of 
EutV (111, 113, 114). In this organism, dimerization promotes binding of EutV at 
four separate locations within the eut gene cluster, preventing formation of intrinsic 
terminators in all instances. More specifically, prior results from our laboratory 




comprised of two helices separated by a short oligonucleotide linker. Each hairpin is 
capped by hexanucleotide terminal loops that resemble one another (113). These 
EutV binding sites are located 5' of eutP, eutG, eutS, and eutA, and have been named 
P1P2, P5P6, P7P8, and P9P10, respectively (113, 132). It was previously speculated 
that the E. faecalis EutV binding site may share conserved features with terminator-
disrupting, putative ANTAR-binding sites in other organisms (114). Interestingly, the 
same features could be identified within the leader regions that are targeted by AmiR 
and NasR, suggesting a common ANTAR:RNA interaction has been evolutionarily 
maintained.  
 From these aggregate findings, we assume ANTAR domains are likely to bind 
to a common RNA substrate. However, putative RNA substrates could not be 
identified for all organisms that have ANTAR proteins, thus suggesting that there will 
be specificity determinants that occur in the nucleotides that are less conserved at the 
primary sequence level. Furthermore, it is likely that there will be specificity 
determinants on the ANTAR-containing proteins that accommodate modified 
substrates. Therefore, the detailed characterization of ANTAR:RNA interactions is 
important, as it will provide key information that can be used to predict ANTAR-
based regulatory networks across diverse organisms. In this chapter, we aimed to 
understand some of the key determinants for ANTAR:RNA interactions. 
3.3 Results and Discussion 
3.3.1 E. faecalis EutV/W TCS promotes antitermination in a heterologous host 
 Previously, we predicted that those proteins that contain an ANTAR domain, 




two-hairpin motif whose distal hairpin directly overlaps a mutually exclusive intrinsic 
terminator (114). However, the strict determinants for RNA recognition by EutV have 
yet to be determined. Moreover, EutV antitermination has not been examined in other 
bacterial hosts, thereby leaving open the possibility that cellular accessory factors 
could participate in antitermination. Unfortunately, in vitro analysis of EutV has been 
complicated by the fact that the purified protein is highly insoluble and exhibits an 
increasing fraction of inactive protein upon purification. Therefore, to characterize the 
requirements of EutV antitermination further we attempted to develop an in vivo 
approach. Specifically, we decided to recapitulate the EutV/W regulatory circuit 
within the heterologous host Bacillus subtilis along with a genetic reporter for 
quantification of antitermination activity. B. subtilis lacks  a eut operon, thus 
eliminating any existing complications from accessory Eut factors. B. subtilis genetics 
are considerably more tractable, thus allowing us to test hypotheses for the protein: 
RNA complex from within this organism. 
To begin to recapitulate the EutV/W genetic circuitry in a heterologous host, the 
E. faecalis eutV and eutW genes were integrated as a two-gene operon into the 
nonessential B. subtilis thrC locus. Furthermore, transcription of the eutVW operon 
was placed under control of PliaI, which is a bacitracin-inducible promoter (Figure 
3.1) (138–140). The P1P2 two-hairpin motif was then placed upstream of a yfp 
reporter gene, but downstream of a constitutive promoter (Pconst) (Figure 3.1). This 
reporter construct was integrated into another nonessential locus, amyE. Since EutV 
is predicted to promote readthrough of P1P2 in response to ethanolamine in E. 












Figure 3-1. Schematic for expression of an E. faecalis EutV antitermination circuit in a 
heterologous host. 1) Control strain containing constitutively expressed yfp for “high” yfp control. 2) 
Control strain containing bacitracin inducible reporter: PliaI eutV/W, for “low” yfp control. 3) Test 






















to ethanolamine dependency (Figure 3-1). However, while ethanolamine is 
catabolized by E. faecalis, B. subtilis is predicted to be unable to metabolize 
ethanolamine. This is likely to explain the high tolerance of ethanolamine exhibited 
by E. faecalis in liquid culture. Since ethanolamine would need to be added to B. 
subtilis in order to study the EutV/W TCS in this organism, we examined the impact 
of ethanolamine on its growth (Figure 3-2). B. subtilis cultures were grown in the 
presence of varying ethanolamine, from 10 µM to 33 mM. Indeed, in 33 mM 
ethanolamine, the concentration we commonly use for induction of the E. faecalis eut 
gene cluster, growth of B. subtilis was dramatically inhibited. We hypothesize that the 
decreased tolerance for ethanolamine in B. subtilis is due to the absence of an 
ethanolamine ammonia lyase enzyme, EutBC. Given these results, we decided on a 
concentration of 5 mM, which resulted in no apparent change in growth yield but is 
likely to still be sufficiently high enough for activation of EutV/W, for study of 
ethanolamine regulation in B. subtilis.  
While 5 mM ethanolamine was not inhibitory to growth of B. subtilis, we 
were not certain whether ethanolamine could traverse the B. subtilis cell wall, and 
thus be used to promote antitermination in a heterologous host. However, it appears 
that B. subtilis might encode for a putative ethanolamine transporter, yxeR (141, 142), 
suggesting EA should be able to enter the cytosol, although this gene has not yet been 
characterized. We then cultured B. subtilis cells in the presence and absence of 5 mM 
ethanolamine and the presence and absence of bacitracin, for induction of eutVW 






Figure 3-2. High [EA] inhibits growth of B. subtilis. B. subitilis grown in the presence of increasing 



































 This test revealed that both EutV/W and ethanolamine were required for YFP 
expression. The presence of EutV/W alone is insufficient to promote readthrough of 
the P1P2 terminator site, resulting in low YFP levels. Therefore, E. faecalis EutV/W 
antitermination could be reduced to only its simplest constituents and fully 
recapitulated in a heterologous host.  
3.3.2 EutX antagonizes EutV antitermination 
 Previously we hypothesized that the EutX sRNA functions to sequester EutV, 
preventing antitermination, thus down regulating gene expression of the eut gene 
cluster (132). To further test the sequestration model of EutX function, we chose to 
introduce it in the B. subtilis host alongside the other components of EutV/W genetic 
circuitry. We speculated if EutX truly acts in trans to sequester EutV in E. faecalis, 
without aid of accessory factors, it would do so in B. subtilis. To test this hypothesis, 
we subcloned the full-length EutX into an extra-chromosomal multicopy vector, 
pDG148 (143–145). However, since no terminator was found downstream of the P4 
stem-loop in EutX, we chose to add a “semi-synthetic terminator” to ensure the full 
EutX transcript was produced. We employed the polyU tract, identified by 3' RACE 
(132), to assist in creation of a strong terminator sequence 
“CCCAACGUUGGGUUUUUUU”. The gene encoding for synthesis of EutX with 
“semi-synthetic terminator” was then transformed into the strain already containing 
the Pconst P1P2-yfp and the PliaI eutVW. EutX expression was induced using 1 mM 
IPTG. As a control for IPTG induction, we also transformed an empty vector control, 












Figure 3-3. E. faecalis EutVW TCS promotes antitermination in a heterologous host. (A) 
Quantification of a strain containing amyE::PconstP1P2T-yfp and thrC::PliaI EutVW in the presence and 
absence of 5 mM EA and/or 30 µg/mL bacitracin. Data quantified using Oufti CellDetection (146). (B) 



































































 Strains were cultured and prepared as the previously described with a few 
exceptions. The pDG148 vectors (empty or containing EutX) were induced at the 
start of outgrowth in the presence or absence of 1 mM IPTG, to ensure that sufficient 
EutX was present at the time of eutVW induction. At mid-exponential growth phase, 
eutVW was induced with 30 µg/mL bacitracin, and 5 mM EA. After 40 minutes of 
incubation, cells were centrifuged and prepared for analytical Fluorescently Activated 
Cell Sorting (FACS) analysis. 30,000 events were counted per strain/condition, and 
then analyzed using Cytobank (147). While the presence of IPTG unexpectedly 
appeared to modestly enhance antitermination activity in the empty vector control, 
induction of EutX exhibited significant reduction of YFP (Figure 3-4). This suggested 
EutX antagonizes EutV antitermination and requires no accessory factors for its 
effects on EutV.   
 Total RNA was then extracted from the appropriate strains and was resolved 
by denaturing polyacrylamide gel electrophoresis, and transferred to a positively 
charged membrane for northern blot analyses. We probed the membrane with a 
radiolabeled antisense RNA to EutX. As a positive control, total RNA was also 
extracted and analyzed from OG1RF grown in the presence of ethanolamine. The 
latter RNA material provided a reference for EutX expression on the northern blots 
(Figure 3-5, first lane). An empty vector control did not show presence of EutX, and 
nor did the undinduced EutX-containing strain (Figure 3-5, middle two lanes), 
suggesting that EutX is expressed as expected. We hypothesize that EutX is indeed 
responsible for the loss of antitermination activity. Under IPTG-inducing conditions a 










Figure 3-4. EutX antagonizes EutV antitermination in a heterologous host. FACS data showing 
effect EutX has on antitermination in the presence or absence of 30 µg/mL bacitracin, presence of 5 
mM EA, and presence or absence of 1 mM IPTG. PliaI eutVW expression is under bacitracin control, 














Figure 3-5. Northern blot analysis of EutX expression in B. subtilis. Total RNA was isolated from 
cells grown in the indicated medium conditions, resolved by denaturing polyacrylamide gel 
electrophoresis, transferred to a membrane, and hybridized with different antisense RNA probes. Efae, 








 3-5, last lane); however, instead of seeing a single full-length product, several 
smaller RNA species could also be identified. We speculate these RNA transcripts 
result from degradation of the EutX sequence expressed in B. subtilis, although it is 
not immediately clear why the sequence is less stable in B. subtilis than that of E. 
faecalis. It is possible that this increased EutX degradation may be due to an 
additional 50 nt of non-native sequence located just upstream of the previously 
identified 5' end of EutX, which might contain instability determinants (132). This 
extra sequence results from subcloning of EutX into the plasmid vector for in vivo 
expression. It is possible that the degradation of EutX in B. subtilis may also explain 
why its production did not result in complete loss of P1P2 antitermination in B. 
subtilis. 
 Alternatively, it is also possible that overexpression of EutV throws off the 
balance of EutV:EutX interactions, thus preventing EutX from completely 
antagonizing EutV antitermination. Under the inducing conditions we chose, it is 
possible that the abundance of EutV is too high, such that EutX cannot sequester all 
of the EutV proteins. As a preliminary test of this hypothesis we sought to determine 
the minimum bacitracin concentration that still promotes EutV antitermination, and 
that could still affect EutX’s ability to antagonize EutV. The level of fluorescence, 
and therefore antitermination activity, was analyzed via analytical FACS upon 
incubation with varying bacitracin. We anticipated that less bacitracin, but constant 
IPTG (for EutX production) would promote further abrogation of antitermination; 
however, instead we saw a proportional change in the amount of antitermination 










Figure 3-6. Heterologous expression of EutX antagonizes EutV. FACS data showing affect EutX 









































































is at least a low level of antitermination always occurring in our heterologous system, 
and that EutX is unable to fully antagonize EutV antitermination activity, possibly 
due to the degradation of EutX in the heterologous host.   
3.3.3 Charged amino acids in ANTAR domain that may be important for 
antitermination 
 In our previous work we identified that the EutV ANTAR domain is sufficient 
for binding P1P2; however, inclusion of the adjacent α-helical region substantially 
increased binding affinity (Figure 3-7, A) (114). Additionally, we established the 
minimum binding requirements for the RNA substrate: a two-hairpin motif whose 3' 
loop overlaps a terminator structure, and that includes two hexanucleotide loops 
where the A in position 1 and G in position 4 appear to be required for 
antitermination function. Conversely, little is known about which portions of ANTAR 
domains are required for binding RNA substrates. To begin investigating which 
amino acids were likely to be important for antitermination activity, we aligned the 
protein sequences of ANTAR-domains from a diverse group of distinct organisms 
that are predicted to be a part of eut gene clusters (79). This comparative sequence 
alignment revealed 33 conserved amino acids in the ANTAR-domain and an adjacent 
extended α-helical segment (Figure 3-7). To investigate where in the EutV protein 
these conserved residues were likely to be positioned, a structural model of the E. 
faecalis EutV protein was generated using the I-TASSER suite (Figure 3-7) (148, 
149). Protein threading of E. faecalis EutV structural model was based on 
Mycobacterium tuberculosis Rv1626. Using this three-dimensional structural model, 






Figure 3-7. Alignment of putative EutV homologues. (A) Structural model of E. faecalis EutV. 
Modeled by threading M. tuberculosis Rv1626 via I-Tasser and Chimera (148, 150). Reciever domain 
in black, α-helix in grey, and ANTAR domain in purple. (B) Aligned eut-associated response 
regulator ANTAR domain proteins ~1-14. P. aeruginosa and K. oxytoca, are not aligned, but their 
ANTAR domain is shown above the secondary structure. Identical residues are denoted by an “*”, 





likely to be involved in intramolecular interactions within the protein core, such as the 
structural interactions formed between alpha helices. (Figure 3-8A, grey boxes). The 
remaining 15 were then chosen for mutagenesis. Specifically, these putatively 
conserved residues were mutagenized to alanines via site-directed mutagenesis 
(Figure 3-8A, blue boxes).  
YFP output was measured for the alanine mutants relative to a strain that 
contained wild type EutV, and then quantified by FACS analysis (147). Of these 
mutants, four of the 15 had no effect on antitermination (Q124A, Q131A, E140A, and 
S171A), two had moderate effect on antitermination (N173A, R175A), and nine 
appeared to completely abolish antitermination activity (Y101A, K104A, M117A, 
R142A, K147A, E160A, Y164A, M172A, and M178A) (Figure 3-8B). To investigate 
whether intracellular abundance of the proteins was altered upon alanine mutagenesis, 
protein extracts were analyzed by Western blotting, using antisera to E. faecalis 
EutV. This revealed that several of the amino acids that exhibited a reduction in 
antitermination activity also exhibited reduced protein levels relative to WT (~40% or 
less; Y101A, K104A, E160A, Y164A, M172A, N173A, R175A, and M178A, data 
not shown). This suggested that the decreased antitermination activity of these 
particular mutants might not be due to the amino acid mutation, but rather to 
instability of the proteins in vivo. Of the three remaining mutants that exhibited full 
loss of antitermination activity, further inspection of the M117A mutation suggested 
the 117 residue could be involved in intramolecular interactions, thus leaving only 
R142A and K147A as representing the most critically important residues for 










Figure 3-8. In vivo antitermination activity of mutant EutV proteins. (A) Schematic showing the 
ANTAR domain with conserved residues highlighted. Grey boxes denote hydrophobic amino acids 
predicted to be involved in intramolecular contacts, while purple boxes denote non-hydrophobic 
residues mutagenized to alanines. (B) FACS data showing affect of mutation on antitermination. Red 
dots denote loss of antitermination activity, yellow dots denote moderate loss of antitermination 
activity, and green dots denote no loss in antitermination activity. Reported median value, error bars 









Since structural models for both AmiR and NasR ANTAR domains have been 
published (135, 137, 151), and since our laboratory has predicted they are likely to 
recognize a similar RNA substrate to E. faecalis EutV, we inspected these protein 
structures for insight into residues that might be generally involved in RNA 
recognition (Figure 3-9). Similarly, a high-resolution X-ray crystallographic structure 
has been resolved for an ANTAR-containing protein (Rv1626) from Mycobacterium 
tuberculosis.  
In the absence of amides, AmiC monomers bind separately to the AmiR 
dimer, causing a conformational change and therefore reducing AmiR RNA-binding 
activity (137). Similarly, in the absence of nitrates or nitrites, the ANTAR domain of 
NasR is unable to bind its RNA substrate (107, 109, 115, 135). Interestingly, the X-
ray crystallographic structures revealed that the ANTAR portions of the monomers of 
NasR and AmiR are superimposable, despite dramatic differences in the dimerization 
interfaces of the overall proteins. NasR utilizes the C-terminus of the third helix in the 
ANTAR domain to assist with dimerization. In contrast, for the unbound state of 
AmiR, the first helix of the ANTAR domain and the extended α-helical region appear 
to participate in creating dimerization interfaces (137). However, only the monomeric 
structure of Rv1626 was resolved by crystallographic analysis, although its ANTAR 
portion superimposes well with structures of NasR and AmiR monomers (151).  
Since both AmiR and NasR crystallographic structures are in the 
unbound/inactive state, and their dimeric configuration is completely different from 
one another, assumptions regarding general EutV structures must be viewed 





Figure 3-9. Electrostatic surface potential maps of AmiR, NasR, and Rv1626 X-ray crystal 
structures. Left are the ribbon structures, and right are the calculated electrostatic surface potential 
maps. Calculations were obtained using the Chimera PDB2PQR APBS (150). The ANTAR domain is 
colored in grey. (A) Crystal structure of AmiR, PDB: 1qo0, a putative positive patch referenced in the 
text is located in the bottom right in the ANTAR domain. (B) Crystal structure of NasR, PDB: 4akk, 
the putative positive patch referenced in the text is located at the top of the “handle”. (C) Crystal 
structure of Rv1626, PDB:1s8n, the putative positive patch referenced in the text is located in the 




presence of amides to prevent AmiC silencing of AmiR, that conformational changes 
will occur that facilitate the ANTAR domains recognition of RNA. Furthermore, 
sequence comparison of the ANTAR domains from AmiR, NasR, Rv1626, and EutV 
indicate that the majority of residues that are strictly conserved are those that are part 
of the hydrophobic cavity of the domain.  
 The three crystal structures, modeled against Rv1626 EutV, suggested there 
may be a putative salt bridge at Q165A/R168A in EutV, and thus were mutagenized 
as follows: Q165A, R168A, Q165A/R168A, and Q165R/R168Q (Figure 3-8 and 3-
10). Interestingly, Q165A showed no change in antitermination activity; however, 
R168A completely abolished antitermination. Not surprisingly Q165A/R168A also 
showed a drop in antitermination activity, but this can be explained by the mutation at 
R168 and not Q165 (Figure 3-8). Finally, Q165R/R168Q restored antitermination 
activity. These mutations argue that the putative salt bridge is unlikely to exist. 
Instead, the Q165R/R168Q mutation suggests that the general location and charge of 
R168 is likely to be important for antitermination activity.  
3.3.4 Putative positively charged patch on surface of the ANTAR domain 
 Previously, calculations of electrostatic surface potential maps 
revealed that there may be a putative positive patch on the surface of the ANTAR 
domain of NasR (135). We found a similar patch in AmiR, and Rv1626 (M. 
tuberculosis) ANTAR domains (Figure 3-9). A similar positive patch is found in E. 
faecalis EutV. Interestingly, upon modeling the other eut-associated ANTAR-domain 
containing response regulators, we see the positive patch appears to be reasonably 













Figure 3-10. Putative positive patch in AmiR, NasR, Rv1626, and EutV. ANTAR helices are 
highlighted in green. Blue boxes denote the residues that are predicted to participate in formation of a 


















Figure 3-11. Electrostatic surface potential maps of putative EutV homologues. (A) EutV from E. 
faecalis.;(B) L. buccalis; (C) A. metalliredigens; (D) D. reducens; (E) C. sticklandii; (F) T. phaeum; 
(F) B. megaterium; (H) B. brevis; (I) L. sphaericus; (J) L. monocytogenes; (K) S. sanguinis; (L) S. 
termitidis. All proteins were modeled using I-Tasser, (148) and electrostatic surface potentials were 




To investigate whether this positive patch was important for antitermination 
activity we chose to mutagenize the positively charged residues in this region to 
alanines: K143, K149 (R142 and R147 were previously caught in the screen for 
conservation), and an additional residue R154 was chosen for this screen due to its 
proximity to the positive patch. Of these alanine mutants K143A showed moderate 
loss in antitermination activity, K149A and R168A showed complete loss in 
antitermination activity, while K154A showed no change in antitermination activity 
(Figure 3-8). Since R142, K143, K147, K149, and R168 alanine mutants showed 
diminished antitermination activity we chose to make more subtle mutations to test 
whether the charge was important for antitermination (lysine to arginine and vice 
versa). If the charge is important for antitermination, we reasoned that replacing a 
similarly sized and charged amino acid with another would restore antitermination 
activity. Interestingly, K143R, K147R, K149R, and R168K were all capable of 
restoring antitermination activity (Figure 3-12). However, R142K did not restore 
antitermination activity, suggesting that the charge at R142 is not the only 
requirement for antitermination activity (Figure 3-12).  This suggested that R142 is 
required for antitermination activity, and that the 142 amino acid may be important 
for RNA:protein interaction to promote antitermination activity, perhaps through 
direct RNA contacts or by affecting protein dimerization.  
3.3.5 nasF ANTAR substrate and NasR cannot function in a heterologous host 










Figure 3-12. Positive patch is required for antitermination activity. FACS data showing affect of 
mutation on antitermination in the presence of 30 µg/mL bacitracin and presence or absence of 5 mM 
EA. Reported median value, error bars denote SD of at least 3 replicate experiments.  Red dots denote 
loss of antitermination activity, yellow dots denote moderate loss of antitermination activity, and green 
dots denote no loss in antitermination activity. Reported median value, error bars denote SD of at least 



































































NasR have similar two-hairpin motifs found in their respective genomes (114). We 
hypothesized that, given the high similarity between two-hairpin motifs in different 
organisms, E. faecalis EutV could promote antitermination at another organisms’ 
ANTAR substrate. To test our hypothesis, we subcloned the nasF two-hairpin motif 
from K. oxytoca into the yfp reporter construct and tested whether EutV could 
promote antitermination at the nasF leader region.  
As before, the strain containing nasF/EutV (amyE::Pconst P1P2nasF-yfp, 
thrC::PliaI eutVW) were grown in rich media to mid-exponential and EutV was 
induced with 30 µg/mL bacitracin and 5 mM EA (Figure 3-13A, blue). After 40 
minutes of incubation, cells were harvested and analyzed using analytical FACS 
(147). Analysis of our FACS data showed that EutV was unable to promote 
antitermination of nasF (Figure 3-13B). We hypothesize that this may be due to 
degradation of nasF, since there are likely to be RNases present in B. subtilis that are 
not present in K. oxytoca. Alternatively, the terminator in the nasF construct may be 
too strong, and thus preventing the two-hairpin motif from forming. However, we 
cannot ignore the possibility that there may be other accessory factors required for 
antitermination in K. oxytoca that are not required in E. faecalis.  
To further test our hypothesis that ANTAR proteins and their substrates can 
be interchanged between organisms, we generated a bacitracin inducible NasR, to be 
paired with E. faecalis Pconst P1P2-yfp reporter (Figure 3-13A, orange). This strain 
was cultured and prepared as the previous FACS experiment with one exception: 







Figure 3-13 . nasF RNA and NasR protein do not support antitermination in a heterologous host. 
(A) Schematic of constructs. Purple is the original strain amyE::PconstP1P2-yfp, thrC::PliaI EutVW. 
Blue: amyE::PconstP1P2nasF-yfp, thrC::PliaI EutVW. Orange: amyE::PconstP1P2-yfp, thrC::PliaI NasR. 
Green: amyE::PconstP1P2nasF-yfp, thrC::PliaI NasR. (B) FACS data showing affect NasF and/or NasR 
have on antitermination in the presence of 30 µg/mL bacitracin and presence or absence of 5 mM EA 







responsive manner, we induced its activity with 10 mM nitrate as previously reported 
by the Stewart lab (115, 116, 152). The two-hairpin motif from E. faecalis coupled 
with NasR was still unable to support antitermination (Figure 3-13B). We postulated 
that this might be due to an inability for nitrates/nitrates to cross the membrane into 
the cytosol to levels that are sufficient to promote antitermination activity. B. subtilis  
has only one nitrate transporter, nasA, which has only been inferred computationally, 
and not experimentally verified, or characterized (141, 142). This could explain why 
NasR might be unable to promote antitermination of the E. faecalis ANTAR 
substrate. Alternatively, nasF RNA and NasR may not function within a heterologous 
host, or perhaps required additional accessory factors. To discern whether it was 
incompatibility of the RNA:protein or issues with the heterologous host, we 
constructed a nasF two-hairpin reporter (amyE::Pconst NasF- yfp) and an inducible 
NasR (thrC::PliaI NasR) strain (Figure 3-13A, green). When we tested this strain for 
antitermination activity we saw that NasR was unable to promote antitermination of 
nasF leader region in a heterologous host (Figure 3-13B).  
3.3.6 In vitro analysis of the ANTAR domain 
 Previous attempts addressing in vitro binding of the ANTAR domain to its 
RNA substrate have been complicated by EutVs’ overall poor solubility and the 
overall high proportion of inactive protein after purification. In contrast, the Stewart 
lab already purified NasR and began to address binding affinity to its RNA substrate 
(109) in response to nitrate/nitrite binding. Therefore, we purified a His10-MBP 
tagged NasR to test whether it bound the nasF two-hairpin motif. Binding was tested 




increasing amounts of the His10-MBP-NasR dimer to trace levels of radiolabeled 
nasF two-hairpin motif (130). Upon addition of micromolar RNA concentrations, 
purified NasR bound to the two-hairpin motif in nasF RNA (Figure 3-14, A). 
Competition with 20 µM cold nasF RNA successfully competed away the interaction, 
while 5 µM and 20 µM of an unrelated RNA, mini-ykkC, was unable to compete 
away the interaction, indicating that binding of NasR is likely to be specific to the 
two-hairpin motif in nasF. As an additional confirmation of specificity, antisense-
EutX (As-EutX) RNA was tested for binding activity, which revealed no binding 
activity for this RNA. In contrast, the apparent Kd value of the His10-MBP-NasR-
P1P2nasF leader RNA complex was estimated to be about 1.6 ± 0.2 µM (Figure 3-14, 
B), which is very similar to the previously reported Kd from the Stewart lab (109). At 
higher concentrations of protein, binding activity began to be reduced, which we 
speculate is due to the increased salts from suspensions of purified NasR. Based on 
the observation that maximal binding activity was observed between 1.25 and 2.5 µM 
nasF RNA to 5 µM NasR dimer, we speculate that the fraction of active NasR was 
between 40 and 50% of total purified protein.  
 To ascertain whether NasR exhibits properties similar to EutV, we 
investigated the functional relevance of a NasR R340 mutation, which corresponds to 
the EutV R142 mutation (Figure 3-10). To that end, we purified His10-MBP-NasR 
R340A and R340K to test nasF RNA binding. Addition of increasing micromolar 
concentrations of the proteins to nasF RNA demonstrated that both mutations 
abolished RNA binding activity. Therefore, the amino acid identity at this position is 









Figure 3-14. nasF RNA binds specifically to NasR. (A) Differential radial capillary action of ligand 
assay (DRaCALA) was used to assess NasR dimer binding to the P1P2nasF RNA. Unrelated RNA, 
mini-ykkC, was used as a negative control for binding specificity. Cold P1P2nasF RNA was used as a 
positive control for competition. (B) DRaCALA was used to assess the apparent Kd of the NasR- 
P1P2nasF  RNA complex. 10 mM NaNO3 was added to each reaction to activate NasR binding to 







binding interactions. (Figure 3-15 A and B, respectively). However, further studies 































Figure 3-15. Mutation of NasR disrupts binding to nasF RNA. (A) DRaCALA was used to assess 
NasR R340A dimer binding to the nasF leader two-hairpin motif. (B) DRaCALA was used to assess 
NasR R340K dimer binding to the nasF leader two-hairpin motif. 10 mM NaNO3 was added to each 
















Our approach to recapitulating this circuit has allowed us to test whether EutX 
was able to sequester EutV without any accessory factors. Indeed, EutX was able to 
sequester EutV; however, it appears that in a heterologous host it may be subject to 
posttranscriptional problems, such as elevated RNA degradation.  
One residue, R142, was found to be well conserved in NasR, Rv1626, EutV 
and other Eut-associated ANTAR domain containing proteins. When R142 was 
mutated to an alanine, antitermination activity was eliminated, suggesting the residue 
provides an important role for antitermination function. Upon mutating R142 to a 
lysine, which should maintain the charge and relative size of the amino acide side 
chain, antitermination activity was not restored. This suggested that the charge alone 
was not sufficient for antitermination activity. For NasR the corresponding residue is 
R340, and mutating this residue to an alanine or a lysine, much like the in vivo EutV 
studies, abolished binding, suggesting that this amino acid is required for 
antitermination activity, possibly through RNA-binding interactions. However, 
further studies on the NasR protein are required to ensure that these mutations do not 
simply disrupt its tertiary structure.  
The catabolism of ethanolamine by E. faecalis has been proven to be quite 
complex with the use of a TCS (Fox et al. 2009; Ramesh et al. 2012) to sense 
ethanolamine, promote antitermination and therefore gene expression of the eut gene 
cluster. In addition, a sRNA, EutX, senses AdoCbl and functions to sequester EutV 
when AdoCbl levels are low (132). Experiments in this chapter demonstrate that the 




heterologous host, B. subtilis. The tools we created will allow us to continue studying 
































Chapter 4: Enterococcus faecalis can utilize ethanolamine under 
anaerobic and aerobic conditions 
4.1 Author contribution 
Data gathered by Gebbie, M. are in Figs 4-1 through 4-14, data gathered by 
Weiss, C.A., are in Fig 4-4, data gathered by Dr. Kaval, K., are in Figs. 4-5, 4-8, 4-10, 
and 4-12, data gathered by Dr. Debroy, S., are in Figs. 4-13. 
4.2  Introduction 
 Organisms that inhabit the gastrointestinal (GI) tract must exhibit metabolic 
flexibility, such as the ability to catabolize ethanolamine (EA). EA is a highly 
accessible source of nitrogen and carbon as it is a breakdown product of 
phosphatidylethanolamine, an abundant phospholipid in both mammalian and 
bacterial cell membranes (76, 153). It is believed that the host diet and the bacterial 
and epithelial cells in the intestines provide rich sources of EA in nature (76, 77, 153). 
A number of bacteria that inhabit the GI-tract and other environments, including, but 
not limited to species of Salmonella, Enterococcus, Klebsiella, Mycobacterium, 
Clostridium, Escherichia, and Pseudomonas, can utilize EA as a sole source of 
carbon and/or nitrogen (Del Papa and Perego 2008; Scarlett and Turner 1976). EA is 
catabolized into ammonia and acetaldehyde by an ethanolamine ammonia lyase, 
EutBC, where the ammonia can serve as a cellular supply of reduced nitrogen, and 
the acetaldehyde can be converted into the metabolically useful compound acetyl-
CoA (155). The ethanolamine ammonia lyase requires adenosylcobalamin (AdoCbl) 




 Previous studies on E. faecalis by the Perego lab investigated whether the 
presence of oxygen affects utilization of EA, by growing WT E. faecalis in a 
modified minimal media and measuring growth of the bacterial culture (111). They 
found that E. faecalis could grow both in aerobic and anaerobic conditions when 
grown in the modified minimal media supplemented with 100 mM glucose. As 
expected, when no carbon source was supplemented, no growth was observed in 
either condition. EA alone did not support E. faecalis growth in the modified minimal 
media in either aerobic or anaerobic condition. However, the Perego lab found that 
growth of E. faecalis cultures could be enhanced by addition of EA when the media 
was also supplemented with AdoCbl, but only in an anaerobic environment. The 
restriction of growth in the presence of EA to only anaerobic conditions suggested 
oxygen might contribute to genetic regulation of the EA catabolism gene cluster. 
Based on this observation, we sought to investigate whether anaerobiosis plays a role 
in eut gene regulation and EA utilization in E.  faecalis. 
4.3 Results and Discussion 
4.3.1 E. faecalis utilizes EA aerobically 
 There have been multiple reports on EA utilization in E. faecalis and its use as 
a carbon or nitrogen source (111, 156, 157); however, previous studies were limited 
by the microbe’s complex growth requirements (111). These previous studies used a 
modified minimal media comprised of M9 salts, HEPES, yeast extract, enzyme 
cofactors, and essential amino acids. The media was then supplemented with AdoCbl 
and EA under anaerobic conditions (111) to support growth. However, the exact 




undefined source of carbohydrates and amino acids. We sought to better characterize 
E. faecalis growth and utilization of EA, so we designed and purchased a rigorously 
defined chemical medium mixture (Table 1), similar to a defined medium that has 
been used for growth of other Gram-positive cocci (158). When inoculated in CDM 
supplemented with 25 µM AdoCbl in the absence of any carbon source, WT E. 
faecalis (OG1RF) cultures failed to grow (data not shown). However, when the 
organism was inoculated in CDM supplemented with both 0.2% glucose and 25 µM 
AdoCbl, cultures grew robustly (Figure 4-1, black line). Therefore, we conclude that 
the CDM is fully sufficient to support growth of E. faecalis upon addition of a 
carbohydrate source and with addition of AdoCbl.  
 
Table 1.  Composition of chemically defined media (CDM)  
Component          Grams/Liter 
Adenine Sulfate, 2H2O      0.02 
DL-Alanine      0.1 
L-Arginine, FB     0.1 
L-Asparagine, Anhydrous     0.1 
L-Aspartic Acid      0.1 
Biotin      0.0002 
Calcium Chloride, Anhydrous    0.0005 
D-Calcium Pantothenate     0.002 
L-Cystine 3HCl     0.0652 
Folic Acid      0.0008 
L-Glutamic Acid     0.1 
L-Glutamine     0.2 
Glycine      0.1 
Guanine, HCl, H2O     0.02 
L-Histidine, FB     0.1 
Hydroxy L-Proline     0.1 
L-Isoleucine      0.1 
L-Leucine      0.1 
L-Lysine, HCl     0.1249 




 L-Methionine     0.1 
Niacinamide      0.0001 
β-NAD, 3H2O     0.0025 
Para-Aminobenzoic Acid     0.0002 
L-Phenylalanine     0.1 
Potassium Phosphate, Dibasic, Anhydrous    0.2 
Potassium Phosphate, Monobasic, Anhydrous    1 
L-Proline      0.1 
Pyridoxal, HCl     0.001 
Pyridoxamine, 2HCl     0.001 
Riboflavin      0.002 
L-Serine      0.1 
Sodium Acetate, Anhydrous    2.7126 
Sodium Phosphate, Monobasic, H2O, ACS    7.35 
Sodium Phosphate, Dibasic, Anhydrous    3.195 
Thiamine, HCl     0.001 
L-Threonine      0.2 
L-Tryptophan     0.1 
L-Tyrosine, 2Na, 2H2O     0.1442 
Uracil      0.02 
L-Valine            0.1 
Add to Prepared Sterilized Medium:         
Carbohydrate     0.2% Glucose or Ribose 
Ferric Nitrate, 9H2O 0.7 mg/mL (good for one month)  2.848 mL/L (4.8 µM) 
Ferrous Sulfate, 7H2O 1 mg/mL (good for one month)  10 mL/L (36 µM) 
Manganese Sulfate, H2O 1.7 mg/mL     4 mL/L (40.2 µM) 
NaHCO3 (125 mg/mL) *make fresh*    40 mL/L 
L-Cysteine (35.4 mg/mL) *make fresh*     40 mL/L 
(158) 
 
While addition of glucose supported full growth of E. faecalis, addition of 25 
µM AdoCbl and 10 mM EA only resulted in minimal growth yields for cells cultured 
in anaerobic conditions (Figure 4-1, light blue). In an attempt to enhance growth in 
the presence of AdoCbl and EA we added ribose, which we considered to be a 













Figure 4-1. Growth of E. faecalis in CDM. WT E. faecalis exhibits enhanced growth in the presence 
of glucose (black), but not in EA (blue) alone or ribose alone (black dotted). 0.2% ribose and 10 mM 
EA supports anaerobic growth of WT E. faecalis. OG1RF was grown in CDM supplemented with 25 



























Under these conditions, growth increased to levels comparable to the glucose culture 
(Figure 4-1, light blue line). Based on its defined composition and its ability to 
support E. faecalis growth, all experimentation on E. faecalis in our laboratory was 
shifted to rely upon CDM supplemented with 0.2% ribose, 25 µM AdoCbl, and, when 
desired, 33 mM EA.  
 To test whether E. faecalis could utilize EA aerobically, we inoculated CDM 
supplemented with 0.2% ribose and 25 µM AdoCbl in the presence or absence of 33 
mM EA with overnight cultures of a WT E. faecalis, EFKK6 (an OG1RF strain that 
contains an eutM:gfp integrated at a nonenssential locus; see Table 8). The bacterial 
cells were first prewashed in CDM to eliminate contaminating nitrogen/carbon 
sources, and inoculated to a starting OD600 of 0.1. The cultures were incubated at 
37°C, while shaking to promote oxygenation, and growth was monitored via klett 
colorimeter every 30 minutes until stationary phase was reached. Under these 
conditions, E. faecalis cultures grew poorly in the absence of EA (Figure 4-2 B, 
empty circles). However, growth was moderately enhanced with addition of EA, as 
evidenced by an overall increased OD600 for stationary phase cells (Figure 4-2 B, 
filled circles). Interestingly, aerobic growth of this strain in the presence of EA lead to 
slower growth rate, 141 ± 3 min per doubling, while the absence of EA was faster at 
69 ± 9 min (Table 2). We hypothesize that the slower growth rate in the presence of 
EA in an aerobic environment may be influenced by the taxing nature of transcribing, 
and translating the entire ~17 kb eut gene cluster required for EA utilization. 
However, while the growth rate was slower, the total number of generations during 












Figure 4-2. E. faecalis utilizes ethanolamine aerobically in CDM. (A) Growth curves of EFKK6 in 
anaerobic cultures, standing. (B) Growth curves of EFKK6 grown in shaking cultures.  (A-B) Both 
cultures were grown in chemically define media (158) supplemented with 0.2% ribose and 25 µM 













Table 2. Analysis of EFKK6, OG1RF, and ΔEutX growth in CDM 
Anaerobic  Anaerobic  Anaerobic  
EFKK6 G n OG1RF G n  ΔeutX G n 
(-) EA 117 ± 4 1.8  160 ± 47 1.6  129 ± 5 1.9 
(+) EA 71 ± 13 2.2  134 ± 1 2.5  1301± 17 3 
Aerobic  Aerobic    Aerobic    
EFKK6 G n OG1RF G n  ΔeutX G n 
(-) EA 69 ± 9 2.6  86 ± 8 3.3  94 ± 4 2.6 
(+) EA 141 ± 3 3.9   115 ± 4 3.9   79 ± 13 3.9 
Data shown are mean ± SD of two independent samples. 
G is generation time in min/doubling 
n is number of generations 
 
4.3.2 Complex media components inhibit aerobic EA utilization 
 Previous studies on EA utilization in E. faecalis employed a modified minimal 
media (111, 112) that contained 2 g/L yeast extract. Their results suggested that E. 
faecalis could only utilize EA under anaerobic conditions; however, given the added 
yeast extract, we could not be certain that EA was the only carbon/nitrogen source 
being used. We postulated that the presence of yeast extract might somehow be 
inhibitory to EA utilization in an aerobic environment. To test this, E. faecalis 
EFKK6 was cultured in CDM supplemented with 0.2% ribose and 25 uM AdoCbl, in 
the presence or absence of EA and 2 g/L yeast extract. As before, we observed 
enhanced growth in the presence of EA when yeast extract was omitted (Figure 4-3A, 
solid vs dotted line), relative to cultures that lacked EA. However, when this strain 
was grown in medium supplemented with yeast extract it did not exhibit growth 
enhancement in the presence of EA (Figure 4-3B, filled vs empty cirlces). On the 
contrary, while both the presence and absence of EA lead to the same number of 
generations, ~2.4 (Table 3), the growth rates were considerably different. In the 













Figure 4-3. Yeast extract inhibits the ability of E. faecalis to utilize EA. (A) Growth curves of WT 
E. faecalis grown in shaking cultures. (B) Growth curves of WT E. faecalis in anaerobic cultures, 
standing. (A-B) Both cultures were grown in chemically define media (158) supplemented with 2 g/L 










minutes, while in the presence of EA this increased to 175 ± 6 minutes (Table 3). This 
suggests that the presence of yeast extract inhibits utilization of EA under aerobic 
conditions, potentially contributing to the previously reported requirement for 
anaerobic conditions.  
 
Table 3. Analysis of EFKK6 growth in CDM supplement with yeast extract 
  Aerobic     
   G n   
(-) EA   114 ± 13 2.4   
(+) EA   175 ± 6 2.4     
Data shown are mean ± SD of two independent samples. 
G is generation time in min/doubling 
n is number of generations 
 
4.3.3 Visualization of Eut microcompartments 
 The enhanced growth observed for E. faecalis in the presence of EA under 
both aerobic and anaerobic conditions suggested that EA is being catabolized. Many 
organisms that catabolize EA do so within the fully assembled microcompartment 
shell (159). Therefore, we speculated that catabolism of EA in E. faecalis may require 
the formation of Eut microcompartments under both aerobic and anaerobic growth 
conditions. To investigate this hypothesis, we attempted to apply two approaches: (1) 
live-cell imaging of microcompartments using fluorescence microscopy and (2) 
transmission electron microscopy.  
 We reasoned that a fluorescently-tagged microcompartment shell protein 
might result in fluorophores tightly associated with the microcompartment organelle. 
There is precedence for this idea; a prior proof-of-principle study on the imaging of 




translationally fused to GFP (160). In that study, multiple GFP-intensive spots were 
observed inside cells, which the authors interpreted as corresponding to locations of 
carboxysomes. Therefore, for imaging of E. faecalis Eut microcompartments, we 
attempted to develop a similar approach. Such an approach would, in the long-term, 
enable the investigation of many different aspects of the biology of bacterial 
microcompartments, from genetic regulation, to biogenesis, to localization, and 
perhaps even to disassembly. To that end, a structural shell protein for Eut 
microcompartments, EutM, was fused in-frame to GFP, and integrated into the 
endogenous eut locus. After culturing this strain in the presence of EA under aerobic 
conditions, an aliquot of the cells at mid-exponential was removed and placed on an 
agarose pad (1.5% agarose in 1X PBS), and subjected to analysis by fluorescence 
microscopy. Interestingly, instead of seeing multiple foci, as predicted for 
microcompartment formation (132), we saw a single, exceptionally bright focal point 
for GFP fluorescence (Figure 4-4), which for diplococcal cells always appeared to be 
positioned at the cellular pole opposite to the cellular division septum. To investigate 
these cells further, samples of cells cultured under the same growth conditions were 
subjected to transmission electron microscopy (TEM). The corresponding 
micrographs revealed widespread cytological features that are consistent with septal 
defects (Figure 4-5, left vs right). No apparent microcompartments were observed for 
this strain. Also, for the EutM-GFP-containing strain there are aberrant cellular 
features at the poles opposite of the division septum that look qualitatively similar to 
large sites of protein aggregation. These results combined suggested that this 








Figure 4-4. Endogenously integrated eutM:gfp hinders Eut microcompartment formation. This 
strain was grown in CDM supplemented with 0.2% ribose and 25 µM AdoCbl in the presence or 
absence of 33 mM EA. Cells were collected at early stationary and washed in 1x PBS, and placed on a 
1.5% agarose pad for imaging. In the presence of ethanolamine only, green foci are found localized to 














Figure 4-5. TEM images of the endogenously integrated eutM:gfp shows septal defects. This strain 
was grown in CDM supplemented 0.2% ribose and 25 µM AdoCbl in the presence of 33 mM EA. 
Cells were collected at early stationary and washed in 1x PBS, and resuspended in 3% glutaraldehyde. 










GFP-tagged EutM protein.   
 One possible reason why the EutM-GFP strain failed to form functional 
microcompartments is that the sole cellular source for EutM was the GFP fusion 
protein. It is possible that this fusion protein is too disruptive to assembly of 
microcompartments. However, it is also possible that a second copy of EutM, fused to 
GFP and positioned ectopically on the genome, might become incorporated within 
microcompartments at a lower abundance than the EutM protein expressed from the 
eut locus. In that instance, we reasoned, the GFP-containing protein could be simply 
incorporated at a low rate into microcompartments. To test this hypothesis we 
generated a copy of eutM-gfp that was integrated into a distally located ectopic locus. 
This eutM-gfp gene was maintained under genetic regulatory control by the 
endogenous eutM promoter region, including the EutV-responsive antitermination 
site just downstream of the eutM promoter. Therefore, EutM-GFP should be 
expressed from an ectopic locus under the same conditions that the eut gene cluster is 
activated. Analysis of this strain by fluorescence microscopy revealed a moderate 
increase in overall GFP in the absence of EA (Figure 4-6, minus EA), suggesting that 
the eutM-gfp gene was indeed responsive to the EutV regulatory protein. Moreover, 
multiple discrete fluorescent foci were observed within cells that had been cultured in 
the presence of EA, for both exponential (data not shown) and stationary growth 
phase, and for cells that had been cultured under aerobic and anaerobic conditions 
(Figure 4-6, plus EA). We did not see any discernable difference in total fluorescence 
between exponential or stationary phase cultures. This result is initially exciting as it 







Figure 4-6. Fluorescent microscopy of EFKK6 during growth. Green foci, indicative of Eut 
microcompartments are found in the presence of EA. The strain containing the ectopically integrated 
eutM:gfp was grown in CDM supplemented 0.2% ribose and 25 µM AdoCbl in the presence of 
absence of 33 mM EA. Cells were collected at early stationary and washed in 1x PBS, and placed on a 
1.5% agarose pad for imaging on the Zeiss Observer. Z1. Approximately 200 cells were quantified 





microscopy, assuming that the fluorescent foci correspond to fully formed 
microcompartments. Therefore, we interpret our data as showing that E. faecalis is 
likely to form Eut microcompartments under both aerobic and anaerobic conditions in 
order to catabolize EA, and that anaerobiosis is not likely to be required for EA 
catabolism. 
 Fluorescence microscopy has distinct limitations, specifically that the 
threshold of resolution is 150 nm, which is coincidentally the average size of bacterial 
microcompartments. Thus, we must be cautious about interpreting the discrete foci 
that we observed as strictly corresponding to the formation of Eut 
microcompartments. Instead, a more cautious interpretation until higher resolution 
microscopy approaches are utilized is that an increase in GFP corresponds to 
confirmation that the eut gene cluster has been upregulated, and that the foci may 
correspond to microcompartments. Nonetheless, observation of EA-dependent, 
fluorescent foci under aerobic conditions are consistent with production of 
microcompartments.  
To further test whether Eut microcompartments are actually being formed we 
decided to employ a higher resolution microscopy, TEM. Cells were cultured under 
the conditions described above and treated as appropriate for microtome sectioning 
and TEM analyses. Inspection of the corresponding micrographs revealed the 
presence of putative microcompartments when bacterial cells were cultured in the 
presence of EA, regardless of the presence or absence (data not shown) of oxygen 
(Figure 4-7). Furthermore, no microcompartments are detected when cells were 











Figure 4-7. TEM images of EFKK6. EFKK6 was grown in CDM supplemented 0.2% ribose and 25 
µM AdoCbl in the presence of absence of 33 mM EA. Cells were collected at early stationary and 











micrographs indicated that EFKK6 produces approximately 1.7 ± 0.1 
microcompartments/cell (Table 4). However, TEM micrographs of cells cultured in 
the presence of EA demonstrated contorted cells that appear to be stressed, and that 
appear to have expressed biofilm extracellular polysaccharides that surround them. 
This suggests that while the ectopically-integrated eutM-gfp is likely to support Eut 
microcompartment formation, expression of the eutM-gfp appears to have adverse 
affects on cellular morphology, including possible septal defects. 
Our data on the strain containing an ectopically integrated eutM-gfp (EFKK6), 
suggested that it might exhibit cytological defects; possibly as a result of the eutM-gfp 
fusion. Therefore, we sought to compare EFKK6 with E. faecalis, which is the same 
but simply lacks the eutM-gfp fusion. We began by examining growth of OG1RF in 
CDM supplemented with 0.2% ribose and 25 µM AdoCbl in the presence or absence 
of EA. This revealed that while EFKK6, the strain containing the ectopically 
integrated eutM-gfp, grew at a rate of 117 ± 4 (Table 2) minutes/doubling 
anaerobically in the absence of EA, OG1RF grew at a rate of 160 ± 
47minutes/doubling (Figure 4-8A, filled circles, and Table 2), taking roughly 15-30% 
more time per generation. This difference in anaerobic growth rate was also apparent 
in the presence of EA, when EFKK6 grew at a rate of 71 ± 13 (Table 2) 
minutes/generation and OG1RF grew at a rate of 134 ± 1 (Figure 4-8A, filled circles, 
Table 2). This disparity in growth rates decreased under aerobic conditions in the 
absence of EA when EFKK6 exhibited a growth rate of 69 ± 9 and OG1RF at 86 ± 8 
minutes per generation (Figure 4-8B, filled circles, Table 2). However, under aerobic 












Figure 4-8. WT E. faecalis supports growth in the presence of EA aerobically. (A) OG1RF 
exhibits a moderate growth enhancement in the presence of EA anaerobically.  (B) OG1RF exhibits 
enhanced growth in the presence of EA aerobically. (A-B) OG1RF was grown in CDM supplemented 











the presence of EA the growth rate disparity diminished. OG1RF demonstrated a 
growth rate of 115 ± 4 minutes/doubling (Figure 4-8B, empty circles, Table 2), while 
EFKK6 produced a growth rate of 141 ± 3 minutes/doubling (Table 2). It was 
interesting that moderately faster growth rates were observed for EFKK6 under all 
four conditions relative to the true WT-strain, OG1RF. However, while we saw a 
moderate difference in growth rate, OG1RF still grew to a higher final cellular yield 
(Figure 4-8B). Therefore, we speculate that the gfp fusion protein exhibited a 
moderate biological effect on E. faecalis growth. To examine microcompartment 
formation, OG1RF was subjected to analysis by TEM for cells cultured in aerobic 
conditions and in the presence of EA. Under these conditions, the TEM micrographs 
revealed the presence of microcompartments. Furthermore, the cells appeared to be 
healthy (Figure 4-9). However, comparison of the number of Eut microcompartments 
that formed in the presence of EA for OG1RF versus EFKK6 revealed slightly more 
Eut microcompartments for EFKK6 (Table 4). One possible interpretation for this 
result is that the increased microcompartment formation may be due to an overall 
increase in shell proteins for the EFKK6 strain. 
4.3.4 Decoupling EutX from the eut pathway enhances growth and increases Eut 
microcompartment formation 
To further explore the utilization of EA under aerobic conditions, we 
investigated the role of EutX in microcompartment formation. A EutX deletion strain 
was inoculated into CDM supplemented with 0.2% ribose and 25 uM AdoCbl and 
grown in the absence or presence of EA and oxygen. Growth of the bacterial cultures 












Figure 4-9. TEM images of OG1RF. OG1RF are grown in CDM supplemented 0.2% ribose and 25 
µM AdoCbl in the presence of absence of 33 mM EA. Cells were collected at early stationary and 











The EutX deletion strain exhibited a growth rate of 109 ± 34 minutes per doubling 
(Figure 4-10A, filled circles, and Table 2) under anaerobic conditions in the absence 
of EA. Interestingly, the growth rate slowed in the presence of EA to 130 ± 30 
minutes per doubling (Figure 4-10A, empty circles, and Table 2). However, while the 
∆eutX strain exhibited a decreased growth rate, it also demonstrated a nearly two-fold 
increase in the total number of generations in the presence of EA relative to the 
absence (Table 2).  
We then asked whether the presence of oxygen impacted EA utilization and 
Eut microcompartment formation in the ∆eutX strain. Under aerobic conditions the 
∆eutX strain exhibited enhanced growth rate in the absence of EA at 94 ± 4 minutes 
per doubling (Figure 4-10B, filled circles, and Table 2), relative to anaerobic growth; 
however the addition of EA did not significantly change the growth rate (Figure 4-
10B, empty circles, and Table 2). While the aerobic growth rates did not appear to 
change much regardless of the presence or absence of EA, we did observe an overall 
increase in cellular yield. The absence of EA only doubled  ~2.6 times, while the 
presence of EA increased the number of doublings to nearly 4.  
The ∆eutX strain was then subjected to analysis by TEM to investigate 
whether the enhanced growth in the presence of EA under aerobic conditions was  
 
 
Table 4. Quantification of microcompartments in EFKK6, OG1RF, and  ΔeutX 
 EFKK6 OG1RF  ΔeutX 
 Avg. SD Avg. SD Avg. SD 
(+) EA 1.7 0.1 0.9 0.1 3.2 0.3 












Figure 4-10. EutX deletion supports enhanced growth in EA. (A) eutX exhibits a moderate growth 
enhancement in the presence of EA anaerobically. (B) eutX exhibits enhanced growth in the presence 
of EA aerobically. (A-B) eutX was grown in CDM supplemented 0.2% ribose and 25 µM AdoCbl in 










indeed due to increased microcompartment formation. Cells were collected from 
early stationary phase and processed them for TEM analysis. This analysis revealed 
that no microcompartments were formed when cells were grown in the absence of 
EA. In contrast, there was an overall increase in microcompartments when the strain 
was cultured in the presence of EA (Figure 4-11, table 4). Quantification of the ∆eutX 
strain revealed approximately 3.2 ± 0.3 microcompartments/cell, nearly double as the 
EFKK6 strain. The increased number of microcompartments per cell and the 
enhanced overall growth in the presence of EA supports a hypothesis that in the 
absence of EutX, EutV can fully promote eut gene expression. Furthermore, when the 
∆eutX strain and OG1RF are grown in minimal media containing EA or EA and 
AdoCbl and visualized by TEM, microcompartments are observed for the ∆eutX 




Previous work (111, 112) suggested a role for oxygen in EA catabolism, 
specifically, that E. faecalis required an anaerobic environment to utilize EA. We 
hypothesized originally that there are at least three possible explanations for the 
dependency on oxygen. (1) It is possible that oxygen is incorporated as a signal for 
genetic regulation of the eut gene cluster. (2) Alternatively, a reduced level of oxygen 
in the microcompartments could improve enzymatic reactions incorporated within 
them. (3) It is also possible that an overall dependency on oxygen is due to a general 
















Figure 4-11. TEM images eutX mutant. eutX are grown in CDM supplemented 0.2% ribose and 25 
µM AdoCbl in the presence of absence of 33 mM EA. Cells were collected at early stationary and 



























Figure 4-12. EA alone induces microcompartment formation in a eutX mutant. Wild type and 
eutX strains were grown in minimal media containing EA or EA and AdoCbl and visualized by TEM. 
Microcompartments, indicated by the red arrows were visible in the strain lacking EutX when grown in 
















this chapter, we can conclude that oxygen does not play a role in genetic regulation of 
the eut gene cluster.  
Our data also suggests that oxygen is not inhibitory to microcompartment 
function in aerobic conditions. Instead, our data supports the hypothesis that 
anaerobic conditions may be required due to an effect of oxygen on AdoCbl 
synthesis. Therefore, our data demonstrate that oxygen is not a genetic regulatory 
feature of EA utilization in E. faecalis. Furthermore, we have established a 
chemically defined media (CDM) supplemented with ribose, AdoCbl, and EA, to 
study EA utilization in E. faecalis, and potentially other Gram-positive organisms.  
 In some species, such as Salmonella enterica, the organism cannot utilize EA 
aerobically due to the restriction of de novo AdoCbl synthesis occurring only under 
anaerobic conditions. This anaerobic requirement is due to the oxygen sensitivity of a 
precorrin intermediate (161, 162). The anaerobic requirement for EA utilization also 
ties into the hypothesis that the Eut microcompartment (78, 88) may facilitate an 
anaerobic environment for such sensitive reactions to take place; however, this has 
yet to be investigated in depth.  However, E. faecalis does not synthesize AdoCbl de 
novo, but instead scavenges cobalamin and produces AdoCbl from a corrinoid 
cobalamin adenosyltransferase encoded by eutT (72), eliminating the oxygen 
sensitivity. This suggests that oxygen may not inhibit EA utilization in E. faecalis.  
 It is interesting that yeast extract appears to inhibit EA utilization. Yeast 
extract is a complex and undefined source of carbon, therefore, we hypothesized that 
carbon regulation may factor into EA utilization. We sought to test this hypothesis by 












Figure 4-13. Glucose inhibites EA utilization in E. faecalis. WT E. faecalis exhibits enhanced 
growth in the presence of glucose regardless of the presence of EA. However, 0.2% ribose alone is not 
sufficient to support growth, but adding 10 mM EA enhances growth to that of the glucose containing 
cultures. OG1RF was grown in CDM supplemented 0.2% ribose or 0.2% glucose and 25 µM AdoCbl 
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supplemented with 25 uM AdoCbl, 0.2% glucose (PTS sugar) or 0.2% ribose (non-
PTS sugar) in the presence or absence of 10 mM EA. OG1RF grew well in 0.2% 
glucose (Figure 4-13, black solid line), as expected, but exhibited no increase in 
growth when supplemented with 10 mM EA (Figure 4-13, blue solid line). From this 
observation, we hypothesized that glucose may participate in genetic regulation of the 
eut gene cluster. Furthermore, when OG1RF was grown in CDM supplemented with 
a non-PTS sugar, ribose, very little growth was observed (Figure 4-13, black dashed 
line); however, growth was greatly enhanced, to that of the glucose culture, when 10 
mM EA was also present (Figure 4-13, blue dashed line). Furthermore, we previously 
noticed that a eutS promoter-lacZ translational fusion containing a deletion of the 
terminator showed high expression in the absence of EA (113). We hypothesize that 
this observed enhanced lacZ activity might be suppressed in the presence of glucose 
as well as the presence of EutX, suggesting a link to carbon catabolite repression 
(CCR).  
 Carbon catabolite repression generally refers to the mechanism used by 
bacteria to ensure that the most preferred carbon source, in most cases glucose, is 
catabolized first (163). In the presence of glucose, transcription of the utilization 
genes for alternative carbon sources in Gram-positive bacteria is repressed by the 
catabolite control protein CcpA, which binds to the catabolite-responsive element 
(cre) in the promoter region of the regulated operon (163). However, transcription can 
be autoregulated by a non-preferred carbon source when glucose is not present 
through a mechanism that utilizes CcpA, as shown for the sucrose utilization genes in 




only sugars or sugar-derivative sources, we speculate that it is possible that a gene 
cluster encoding for utilization of a non-sugar carbon source, such as EA, may also be 
subject to regulation by CcpA.  
 Since we hypothesize that the eut gene cluster may be regulated by carbon 
catabolite repression, it should contain a recognizable cre site for binding of CcpA. 
By searching the E. faecalis OG1RF eut gene cluster for the cre consensus sequence, 
WTGNAANCGNWNNCW, found for B. subtilis (165, 166), we found a putative cre-
site just upstream of the eutSVW operon. Additionally, the Perego lab identified a 
putative -10 (TATAAT) and -35 (TTGACA) consensus sequence separated by 17 bp 
located in the eutG-eutS intergenic region (111). It is precisely within this 17 bp 
region that the putative cre-site was identified, just upstream of the P7P8 two-hairpin 
motif that serves to control the eutSVW operon. Furthermore, when searching the L. 
monocytogenes eut gene cluster for the cre consensus sequence, we also find a cre-
site just upstream of a two-hairpin motif that serves to control L. monocytogenes 
eutVW operon. Therefore, these data strongly suggest that CcpA may serve to repress 
eutVW expression in the presence of glucose, but when glucose is not present, eutVW 
expression is derepressed, and the eut gene cluster can be upregulated.  
 Works described in this chapter show that E. faecalis not only utilizes EA 
aerobically in addition to anaerobically, but that it incorporates formation of Eut 
microcompartments to do so. Furthermore, we have supported our previous 
hypothesis (132) that EutX serves to sequester EutV. When we decoupled EutX from 
the pathway we saw an enhanced growth in EA regardless of oxygenation conditions. 




but also indicated that more than double the microcompartments formed in this strain. 
In the absence of EutX, specifically P3P4, EutV can antiterminate at the ANTAR 
substrates and increase eut gene cluster expression. Furthermore, while our data in 
this chapter eliminated a genetic role for oxygen in eut gene expression, we speculate 
the eut gene cluster is still subject to additional genetic regulation. Specifically, we 





















Chapter 5:  Summary of primary findings and future directions 
 
5.1 Summary of Primary Research findings 
 A primary motivation for this dissertation research was to investigate how E. 
faecalis incorporates AdoCbl into genetic regulation of the eut locus. Prior to this 
research, several lines of evidence pointed to an AdoCbl-sensing riboswitch located 
in the intergenic region of eutT-eutG, and suggested it may play a role in eut 
regulation. However, these reports differed in how the riboswitch might be acting. 
The Perego group postulated that it behaves as a canonical AdoCbl riboswitch by 
serving as a 5' UTR of eutG or a 3' UTR of eutT, and that binding of AdoCbl would 
promote termination (111, 112). Our lab previously showed evidence that was 
interpreted as showing the AdoCbl riboswitch functions as a 5' UTR of eutG, wherein 
AdoCbl activated antitermination (113). However, this work has resolved this 
question and indicated that the AdoCbl riboswitch serves to sense when cellular 
AdoCbl levels are low, and promotes transcription of a full-length, 300-nucleotide 
sRNA, EutX. EutX contains a two-hairpin motif, P3P4, at its 3' terminus that serves 
to sequester EutV, which in turn prevents antitermination, thereby decreasing 
expression of the eut gene cluster. Conversely, when cellular AdoCbl levels are high, 
the riboswitch adopts an alternative conformation and promotes synthesis of a shorter, 
150-mer sRNA. P3P4 is not present in the shortened sRNA, which is therefore unable 
to sequester EutV (132). In vivo evidence of a strain containing a P3P4 deletion 
confirms that this RNA acts in trans, since its deletion allows for lacZ expression in a 




plasmid or the chromosome is still sufficient to sequester EutV, and thus prevent 
expression of the P5P6-lacZ fusion. Taken together, these results indicate that for the 
first time a riboswitch serves to control a protein sequestration site, and, by doing so, 
exerts regulatory influence over an entire signal transduction pathway.  
 This dissertation also explores the key determinants of ANTAR proteins and 
their substrate binding. Previously, the ANTAR domain of EutV alone was shown to 
be sufficient for binding P1P2 (113). Additionally, the C-G closing base pair, A at 
position 1 and G at position 4, have been shown to be the key determinants of the 
ANTAR substrate (114). However, despite our best efforts to search for them, 
ANTAR substrates have not been identified for a subset of organisms that encode for 
proteins with ANTAR domains. This begs the question: are there other specificity 
determinants that occur in nucleotides that are less conserved at the primary sequence 
level? Furthermore, based on this hypothesis, it is likely that there will be specificity 
determinants in the ANTAR domain that accommodate modified substrates. We have 
identified one amino acid in the EutV ANTAR protein, R142, which is important for 
antitermination activity. R142 in the EutV ANTAR domain can be mapped to R340 
in the NasR ANTAR domain. Mutating R142 to an alanine or a lysine lead to a loss 
of antitermination activity in vivo for EutV, thus suggesting an important role in 
antitermination activity, perhaps involved in RNA-contact. Similarly, upon 
purification of R340A and R340K NasR mutants, we saw loss of RNA-binding 
activity, further confirming an important role for this amino acid in RNA-binding. 




interacting directly with the two-hairpin motif. It would be interesting to discern 
correlations between amino acid residues and their nucleic acid binding partners. 
 Finally, our work in this document attempted to unravel the biological 
requirements for ethanolamine utilization in E. faecalis. Previous work by the Perego 
group had suggested that ethanolamine could only be used as a carbon/nitrogen 
source under anaerobic conditions. However, our data contradict these findings to 
show that E. faecalis is able to catabolize ethanolamine under both aerobic and 
anaerobic conditions, and that Eut microcompartments are fully formed after addition 
of ethanolamine and AdoCbl.  
Interestingly, preliminary data from growth assays in the presence of glucose 
and ethanolamine versus glucose alone showed no enhanced growth with glucose and 
ethanolamine. This observation suggests that glucose, a PTS sugar, might be 
inhibitory to ethanolamine utilization. In Firmicutes, in additions of low glucose 
carbon catabolite repression (CCR) is mediated by binding of CcpA at cre-sites. We 
identified a putative cre-site just upstream of the eutSVW operon. We postulate that 
once glucose reserves are exhausted, eutSVW will be derepressed, and only then will 
E. faecalis catabolize ethanolamine.  
 
5.2 Sensing AdoCbl and EA, and eut Gene Cluster regulation 
 Ethanolamine utilization has been best studied in S. typhimurium, where EutR, 
a DNA-binding transcription factor, functions as a positive regulator of the eut 
operon. Those organisms that lack EutR, such as Firmicutes, instead have a two-










Figure 5-1. Strategies of eut gene regulationin multiple organisms.  (A) E. faecalis eut gene cluster. 
EutW senses EA, while the AdoCbl riboswitch in EutX senses AdoCbl, possible carbon catabolite 
repression by CcpA. (B) S. entericia subsp. Typhimurium eut operon. The DNA-binding transcription 
factor, EutR, is responsible for sensing both EA and AdoCbl. (C) L. monocytogenes eut gene cluster. 
Similar to E. faecalis, L. monocytogenes EutW senses EA, while the AdoCbl riboswitch in Rli55 
senses AdoCbl, possible carbon catabolite repression by CcpA. ( (D) C. difficile eut gene cluster. The 









However, the discovery of EutX adds to these regulatory features. It conceptually 
extends prior sRNAs to demonstrate a mechanism for how protein sequestration can 
be placed under signal responsive regulatory control by a riboswitch, the first of its 
kind (Figure 5-1A) (132). This mechanism is supported by the detection of putative 
EutX-like orthologs in L. monocytogenes (Figure 5-1C), and Streptococcus sanguinis. 
However, in S. sanguinis, the riboswitch and ANTAR substrate are inverted relative 
to the adjacent eutG gene and its corresponding ANTAR substrate (131). 
Collectively, our results indicate how organisms that lack EutR sense and respond to 
AdoCbl to regulate eut gene expression. Furthermore, our results expand the 
mechanisms by which riboswitches can regulate gene expression. Conversely, some 
organisms, such as Clostridium difficile, appear to encode for the two-component 
system EutV/W and possibly ANTAR substrates, but do not seem to have an AdoCbl 
sensing riboswitch (Figure 5-1D). How these organisms sense and respond to cellular 
concentrations of AdoCbl is not yet known.  Future studies of how these organisms 
sense and respond to AdoCbl may reveal additional novel or modified mechanisms 
and add again to the repertoire of eut operon regulation strategies. 
5.3 Biological Relevance of Ethanolamine Utilization in E. faecalis 
 Catabolism of ethanolamine in E. faecalis was once thought to occur only in 
an anaerobic environment. This hypothesis was based on the anaerobic requirement 
of S. typhimuriums for de novo synthesis of AdoCbl, a required cofactor for 
ethanolamine breakdown. However, our results show that a complex media 
containing yeast extract, which we have shown inhibits the proper use of 







Figure 5-2. Final model for E. faecalis eut gene regulation. The presence of glucose activates CcpA 
to bind at a putative cre-site upstream of the eutSVW operon. In the absence of glucose, and presence 
of ethanolamine EutW senses ethanolamine, autophosphorylates, and transfers its phosphoryl group to 
EutV promoting dimerization and activation. EutV then promotes antiterminates at the indicated two-
hairpin motifs (green). AdoCbl (B12) is sensed by the AdoCbl riboswitch found within EutX. P3P4 
two-hairpin motif of EutX sequesters EutV, preventing antitermination, thus down regulating the eut 








a feature of eut gene regulation, and that E. faecalis can utilize ethanolamine under 
both aerobic and anaerobic conditions. Furthermore, we observed that the presence of 
glucose in the media also inhibits the use of ethanolamine under both aerobic and 
anaerobic conditions. This suggests a possible role for carbon catabolite repression, 
and therefore CcpA in regulating the eut gene cluster (Figure 5-2). Strengthening our 
argument is a putative cre-site just upstream of the P7P8 two-hairpin motif regulating 
the eutSVW operon. However, this cre-site is untested, and therefore experiments are 
required to determine if the eut gene cluster is indeed regulated by CcpA.  
 It is interesting that the deletion of EutX allowed for increased Eut MCP 
formation, and that AdoCbl was no longer required. This observation supports our 
model that EutX serves to sequester EutV, preventing downstream eut gene 
expression, thus in the absence of EutX we see increased MCPs. We hypothesize that 
transcript analyses of the eut gene cluster in the absence of EutX will show increased 
expression.  
5.4 Conclusion 
 Works described in this dissertation demonstrate that the eut gene cluster in E. 
faecalis contains several layers of regulation as can be seen in Figure 5-2. We believe 
that these various regulatory elements may extend beyond E. faecalis. For example, 
L. monocytogenes also encodes for a similar sRNA, Rli55, which behaves similar to 
EutX (131). Additionally, a putative cre-site can be found just upstream of the L. 
monocytogenes EutVW operon, suggesting its eut operon is also regulated by carbon 
catabolite repression. This dissertation has served to expand the regulatory roles of 




antitermination, both in vitro (NasR) and in vivo (EutV) in a heterologous host. 
Finally, we have changed the way the field studies E. faecalis EA utilization, and 




















Chapter 6:  Materials and Methods 
 
6.1 Chemicals and oligonucleotides 
 All chemicals and enzymes, unless otherwise noted, were obtained from 
Sigma-Aldrich and New England Biolabs, respectively. DNA oligonucleotides were 
purchased either from Integrated DNA Technologies, Inc. or Sigma-Aldrich. Exact 
nucleotide sequences and brief description of DNA oligonucleotides used in these 
studies can be found in Table 4.   
6.2 Bacterial strains and media 
 The E. faecalis strains used in the an/aerobic studies, and EutX discovery 
(Chapters 2 and 4) were all derivatives from strain OG1RF. All E. faecalis strains 
were obtained from Dr. Danielle Garsin’s lab at the University of Texas Health 
Science Center at Houston. The B. subtilis strains in the heterologous expression and 
ANTAR studies (Chapter 3) were all derivatives from strain 168. All B. subtilis 
strains were obtained from Bacillus Genetic Stock Center (BGSC, Ohio).  
6.2.1 Growth conditions 
 All E. faecalis strains were typically cultured at 37°C in either Brain Heart 
Infusion (BHI, Difco) broth or plates supplemented with 1.5% Bacto agar (Difco), 
Chemically Define Media (CDM, Alphabiosciences), recipe in the Table 1 
supplemented with 0.2% ribose, or 1x M9HY (20 mM HEPES pH 7.0, 2g/L yeast 
extract, 1 mM M9 salts, 1 mM MgSO4, 0.2 mM CaCl2, 1 g/mL thiamin, 0.2 g/mL 




µg/ml folic acid, 0.2 g/mL arginine, 0.2 g/mL glutamate, 0.2 g/mL glycine, 0.2 g/mL 
histidine, 0.2 g/mL isoleucine, 0.2 g/mL leucine, 0.2 g/mL methionine, 0.2 g/mL 
tryptophan, and 0.2 g/mL valine).  
 All B. subtilis strains were typically cultured at 37°C in either 2xYT (16 g 
tryptone, 10 g yeast extract, 5 g NaCl per liter), or on Tryptone Blood Agar Base 
(TBAB, Difco) plates.  
 All E. coli strains were cultured at 37°C in Luria Bertani (LB, Difco) broth or 
agar (10 g tryptone, 5 g yeast extract, 5 g NaCl per liter) 
6.2.2 Antibiotic concentrations 
 When appropriate, antibiotics were used at the following concentrations 
(µg/ml) for E. coli: ampicillin, 50; carbenicillin, 100. Antibiotics were used at the 
following concentrations (µg/ml) for B. subtilis: spectinomycin, 100; erythromycin, 1 
and lincomycin, 25; chloramphenicol, 5; neomycin, 5. Antibiotics were added at the 
following concentrations (µg/ml) for E. faecalis: erythromycin, 50; and rifampicin, 
100.  
6.2.3 Amino acid concentrations for auxotrophs 
 B. subtilis 168 is an tryptophan auxotroph, and 50 µg/ml tryptophan was 
added for all experiments of this strain and its derivatives. Any strain with a 
disruption to the thrC gene creates a threonine auxotroph, thus 50 µg/ml threonine 
was added for all experiments of these strains and its derivatives.  
 
6.2.4 Inducer concentrations 




gene expression and protein expression/activity with final concentrations of 1 mM, 30 
µg/ml, 33 mM (E. faecalis) and 5 mM (B. subtilis), and 25 µM, respectively.  
6.3 Strain construction 
 All bacterial strains used in this dissertation are listed in Table 7. 
6.3.1 Construction of amyE:: Pconst P1P2T-YFP 
 Plasmid pDG1662 contains regions of the amyE gene and was thereby used to 
integrate a gBlock containing Pconst P1P2T-YFP with flanking arms of homology to 
amyE within the amyE gene via double recombination. Oligonucleotides and gBlocks 
used to make this strain are listed in Table 4 and 5. 
6.3.2 Construction of thrC:: PliaII EutVW 
 Plasmid pDG1664 containg regions of the thrC gene and was thereby used to 
integrate a gBlock containing PliaI EutVW with flanking arms of homology to thrC 
within the thrC gene via double recombination. Any mutations to EutV were done so 
using oligonucleotides specific for Q5 site-directed mutagenesis (New England 
Biolabs). Oligonucleotides and gBlocks used to make these strains are listed in Table 
4 and 5. 
6.3.3 Construction of inducible EutX 
 To the EutX sequence a semi-synthetic terminator (SST) was added. The 
semi-synthetic terminator was derived from the original termination poly-U tract 
found using RACE, and making a stronger terminator sequence. This semi-synthetic 




added sequence. Next, the EutX with SST was cloned into pDG148. Oligonucleotides 
used to make these strains are listed in Table 4 
6.3.4 Construction of inducible GlmS-P3P4 
 To the GlmS sequence (167) the linker region and P3P4 of EutX was added 
followed by the same SST. This was purchased from IDT as a gBlock with flanking 
arms of homology to the pDG148 vector. Next, this gBlock was cloned into pDG148. 
A derivative strain, GlmS (M9 mutant)-P3P4 was generated by Q5 site-directed 
mutagenesis (New England Biolabs). Oligonucleotides and gBlocks used to make 
these strains are listed in Table 4 and 5. 
6.3.5 Construction of thrC:: PliaI NasR 
 A gBlock containing NasR from K. oxytoca codon optimized for B. subtilis 
was ordered from IDT. Plasmid pDG1664 containg regions of the thrC gene and was 
thereby used to integrate a gBlock containing PliaI NasR with flanking arms of 
homology to thrC within the thrC gene via double recombination. Any mutations to 
NasR were done so using oligonucleotides specific for Q5 site-directed mutagenesis 
(New England Biolabs). Oligonucleotides and gBlocks used to make these strains are 
listed in Table 4 and 5. 
6.3.6 Construction of NasR expression vector 
 Codon optimized NasR was amplified in-frame with a His10-MBP tag from 




6.3.7 Genetic transformation of E. coli 
 All Gibson assemblies, Q5 site-directed mutageneses, and subcloning 
reactions were transformed as follows: 5 µL of the cloning reaction was transformed 
into 50 µL chemically competent XL10Gold E. coli. The DNA was incubated with 
the cells for 30 minutes on ice. The mixture was heat treated at 42°C for 30 seconds 
followed by recovery on ice for 5 minutes. 250 µL of rich media was added to the 
cells for an hour outgrowth at 37°C. 100 µL of the reaction was plated on an LB plate 
with the appropriate antibiotic. 
6.3.8 Genetic transformation of B. subtilis 
 All strains were transformed with 1-10 µg plasmid DNA using the one-step 
method. Briefly, the recipient strains were inoculated from a single colony into 
transformation media (12.5g of K2HPO4, 3 g of KH2PO4, 0.5g trisodium citrate, 
0.1g MgSO4, 1g Na2SO4, 50µM FeCl3 2µM MnSO4, 0.4% glucose and 0.2% 
glutamate in 500 mL of water) supplemented when appropriate with 50 µg/mL 
tryptophan and or threonine, and placed in a 37 ̊ C incubator standing over night. The 
following day they were placed in a shaking incubator and the OD600 was monitored 
until the cultures reached exponential phase (between 0.4 and 0.8) and were then 
inoculated with plasmid DNA. The cultures were subsequently replaced in the 
incubator shaking for 45 minutes. Next, 2xYT (containing 0.1 µg/mL 
chloramphenicol or erythromycin when the donor strain was resistant to either) was 
added to the culture for outgrowth and recovery, and replaced in the incubator 
shaking for an additional 45 minutes. Lastly, the cultures were plated onto a TBAB 




6.4 RNA extraction 
 Cells were harvested by centrifugation at 5,700 rpm for 10 minutes at which 
point pellets were frozen at -80°C until ready for RNA extraction. To extract total 
RNA, the cell pellet was briefly thawed and resuspended in 750 µL LETS buffer (0.1 
M LiCl, 10 mM EDTA pH 8.0, 10 mM Tris-HCl pH 7.4, and 1% SDS) and disrupted 
by continuous vortexing with 400 µL glass beads for four minutes followed by 
incubation at 55°C for five minutes. The suspension was centrifuged for ten minutes 
at 15,000 rpm and the supernatant collected and mixed with 1 mL TRI reagent 
(Ambion AM9738) with incubation at room temperature for five minutes. 200 µL 
chloroform was then added and the suspension was mixed vigorously for 15 seconds 
followed by a two minute incubation at room temperature. The samples were 
centrifuged at 15,000 rpm for 15 minutes and the top 60% (approximately 600 µL) of 
the phase-separated mixture was collected and precipitated with 1 mL isopropanol for 
10 minutes at room temperature. Precipitated RNA was washed with 200 µL of 70% 
ethanol and resuspended in 20 µL purified water.  If the RNA samples were to be 
used for qRT-PCR, the samples were treated with DNase I from Promega per 
manufacturer’s instructions.  
6.5 Northern blot analyses 
 Total RNA samples (10-20 µg) were heated at 65°C for 10 min in 1x gel 
loading buffer (45 mM Tris-borate, 4 M urea, 10% sucrose [w/v], 5 mM EDTA, 
0.05% SDS, 0.025% xylene cyanol FF, 0.025% bromophenol blue) and resolved by 
6% denaturing (8 M urea) polyacrylamide electrophoresis. Aliquots of an Ambion® 




generate an RNA size standard curve. RNA within the polyacrylamide gels was 
transferred to BrightStar-Plus nylon membranes (Ambion) using a semi-dry 
electroblotting apparatus (Owl Scientific) in 1X NAQ buffer (4 mM MOPS, 1 mM 
sodium acetate, 0.1 mM EDTA) at 2 mA/cm2
 
for 1 hour. The blots were UV-
crosslinked at 125 mJ and hybridized overnight at 42°C in UltraHyb Oligo Buffer 
(Ambion) in the presence of different radiolabeled (32P) antisense RNA probes or 
(32P) DNA oligonucleotide probes. The blots were the washed twice for 15 minutes 
using low stringency buffer (1X SSC, 0.1% SDS, 1 mM EDTA) and then for 30 
minutes using high stringency buffer (0.2X SSC, 0.01% SDS, 1 mM EDTA) 
Radioactive bands were visualized using ImageJ software and a FLA5000 
Phosphorimager.  
 
6.6 Rapid Amplification of cDNA Ends (RACE) 
6.6.1 With 5' adenylated linkers 
 E. faecalis OG1RF was grown in minimal medium containing supplemental 
AdoCbl and EA, or EA alone. After 3.5 hours of anaerobic growth, cells were 
harvested and total RNA was extracted as described above. Total RNA was then 
DNase I-treated (Promega) and subjected to the RiboZeroTM
 
Magnetic Kit (Gram- 
Positive Bacteria) to remove ribosomal RNA according to manufacturers’ protocol. A 
pre-adenylated linker (NEB Universal miRNA Cloning Linker) was incubated with 
T4 RNA ligase KQ (NEB) for 1 hour at 25°C. The reaction was then purified using 
the Zymo-RNA Clean & Concentrator kit. This RNA was incubated with a DNA 




(ATTGATGGTGCCTACAG), and incubated for 10 minutes at 65°C. Then iScript 
reverse transcriptase, buffer, and 5 mM dNTPs were added and the reactions were 
incubated at 42°C, 50°C, 55°C, 60°C for 15 minutes each, followed by 90°C for 5 
minutes. The reaction was then treated with 0.5 µg/µL RNase A for 20 minutes at 
37°C and again purified by the Zymo-DNA Clean & Concentrator kit. This cDNA 
was used as template for PCR amplification, using oligos MG283 and MG285 (Table 
S2). The resulting PCR products were subcloned by TOPO TA reactions according to 
manufacturers’ protocol (Invitrogen) and transformed into Top10 cells (Invitrogen) 
on LB containing 50 µg/mL ampicillin and 40 µg/mL X-Gal. White colonies were 
chosen and the appropriate insert sequences were analyzed by Sanger sequencing.  
6.6.2 From circularized RNA transcripts 
Total RNA was treated with DNase I and then incubated with TerminatorTM 
5'-phosphate dependent exonuclease (Epicentre), according to manufacturers’ 
protocol. Terminator exonuclease-treated RNA was then incubated with Tobacco 
Acid Pyrophosphatase (Epicentre) for full conversion of 5'-triphosphates to 5'-
monophosphates. The RNA was then incubated with T4 RNA ligase (NEB) under 
relatively dilute conditions to promote intramolecular ligations. cDNA synthesis and 
PCR amplification were performed as above using oligos MG293 and MG294 (Table 
S2). The subsequent sub-cloning, PCR amplification and sequencing analyses were 





6.7 In vitro transcription assays 
 The double-stranded DNA template for transcription of the EutX-associated 
riboswitch consisted of a 308 base-pair (bp) PCR fragment. This sequence included 
from -135 to +1 of the B. subtilis glyQS promoter, followed by the EutX-associated 
AdoCbl riboswitch. The DNA template ended at 20 nts after the putative riboswitch 
intrinsic terminator, which was predicted by 3' RACE. A separate control template 
included a mutation (M3) of three cytosines changed to guanines, located within the 
L5 loop, which is known to perturb AdoCbl binding. Synchronized transcription 
assays were carried out as described (16). Template DNA (10 nM) was incubated in 
1X transcription buffer (10 mM Tris pH 8.0, 20 mM NaCl, 14 mM MgCl2, 14 mM β-
ME, and 0.1 mM EDTA pH 8.0) with E. coli RNAP (Epicentre). The dinucleotide 
ApU (150 µM, Tri Link Biotechnologies) was also included to assist transcription 
initiation. ATP and GTP were added at 2.5 µM, UTP was added to 0.75 µM and [α-
32P] UTP (3000 Ci/mmol) was added to 0.33 µM. Transcription was initiated in the 
absence of CTP. The first C in the DNA template sequence was located at +30; 
therefore, the transcription elongation complex halted after synthesis of 29 nt under 
these conditions. The initiation reaction mixtures were incubated at 37°C for 10 min 
and were then placed on ice. Heparin (20 µg/mL, Sigma) was added to block 
reinitiation, and elongation was triggered by the addition of NTPs to 1 mM final. 
Transcription reactions were terminated with 2x urea loading buffer (8 M urea, 20% 
sucrose [w/v], 0.1% SDS, 0.05% bromophenol blue [w/v], 0.05% xylene cyanol FF 
[w/v], 0.09 M Tris-HCl pH 7.5, 0.09 M borate, and 1 mM EDTA pH 8.0) and 




quantified using ImageJ software and a FLA5000 phosphorimager.  
6.8 Quantitative real-time RT-PCR 
 Total RNA from strains was isolated as described above. Approximately 5 µg 
RNA was then incubated in 20 µL reactions with 2 units DNase (QuantBio) per 
manufacturer instructions.  DNA-depleted total RNA was converted to cDNA with 
Quanta Bio qScript cDNA Supermix. The cDNA was diluted in TE buffer and added 
to qPCR reactions made with Quanta Bio PerfeCTa SYBR Green FastMix. All qPCR 
reactions were prepared for 18 µL volumes in 96- or 384-well plates, and analyzed 
using a Roche Lightcycler 480 with the recommended three-step fast cycle. All 
oligonucleotides used for each amplicon are listed in Table ##. All experiments 
utilized negative RNA-only controls for DNA contamination using reference gene 
amplicons. Cq values and amplification efficiencies were determined using 
LinRegPCR (169). Relative quantification was performed relative to gyrB. All 
experiments used at minimum three biological replicates. 
 
6.9 RNA–binding studies using electrophoretic mobility shift assays (EMSA) or 
differential radial capillary action of ligand assay (DRaCALA)  
 RNA transcripts were transcribed and radiolabeled with γ-32P ATP. Similar 
reactions, minus γ-32P ATP, were run to generate cold competitor RNA, which was 
added at 10-fold excess, ~3 µM, to certain controls. Radiolabeled RNA (~300 fmol) 
was incubated with increasing concentrations of protein in a 20 µl reaction containing 
50 mM HEPES pH 7.5, 75 mM sodium chloride, 10 mM MgCl2 and 2.5 ng/µl yeast 




DRaCALA (130). For EMSA, 10 µL of each sample was run on a non-denaturing 6% 
TBE polyacrylamide gel (acrylamide: bis, 29:1). Gells were pre-run for 30 min at 15 
volts, and samples were electrophoresed at 15 volts for 30 minutes to 1 hour, with 
0.5X TBE running buffer, followed by drying for 45 min. For DRaCALA, ~2 µL of 
each sample was spotted on a nitrocellulose membrane using a pin-tool and allowed 
to air dry for 30 min. Gels for EMSA and nitrocellulose membranes for DRaCALA 
were exposed for one hour, visualized, and quantified using ImageStudioLite 
software and an FLA5000 phosphorimager. 
6.10 Protein expression and purification 
 Deca-histidine-tagged NasR was cultured in 2xYT supplemented with 0.2% 
glucose, and expression induced at A260= 0.5 with 1 mM IPTG at RT for 18 h. The 
cell pellet was resuspended in Resuspension buffer (50 mM HEPES pH 8.0, 150 mM 
NaCl, 1 mM MgCl2, 2 mM β-ME, 10 mM Imidazole, 5% glycerol, 1 mM PMSF, 2 U 
DNase). Cells were lysed with 0.5 mg/mL lysozyme for 20 minutes on ice, then 0.1% 
(final) TritonX-100 was added, followed by 1/10th volume 5 M NaCl. The 
resuspension was then sonicated on ice until no longer viscous. After the cell 
disruption and centrifugation, the supernatant was passed over 1 mL Ni-NTA resin 
(Qiagen), followed by 20 column-volumes (CV) wash buffer (50 mM HEPES pH 8.0, 
500 mM NaCl, 1 mM MgCl2, 2 mM β-ME, 20 mM Imidazole, 5% glycerol). The 
protein was eluted in five fractions of 2 CV elution buffer (50 mM HEPES pH 8.0, 
150 mM NaCl, 1 mM MgCl2, 2 mM β-ME, 500 mM Imidazole, 5% glycerol). Eluted 
protein was dialyzed against dialysis buffer (50 mM HEPES pH 8.0, 75 mM NaCl, 1 




were performed either on ice or at 4°C. Purity of NasR was judged by 4-20% 
SDS/PAGE followed by coomassie-staining.  
6.11 Growth curves 
6.11.1 E. faecalis 
 Single colonies of E. faecalis strains were inoculated into BHI broth 
and incubated for 18 h at 37°C. The following day the overnight cultures were 
washed in CDM and inoculated to an OD600 of ~0.1 in fresh CDM supplemented with 
0.2% ribose and 25 µM AdoCbl in the presence of absence of 33 mM EA. 2g/L of 
yeast extract was added as it was required. Aerobic or anaerobic cultures were 
performed as follows: 
6.11.2 Aerobic 
 The cultures were then grown at 37°C shaking, and growth measured every 30 
minutes by Klett colorimeter.  
6.11.3 Anaerobic 
 The 10 mL of media was placed into Klett tubes, and sealed. The vials were 
placed under vacuum for 10 minutes, and then degassed with N2 gas. The cultures 
were then grown at 37°C standing, and growth measured every 30 minutes by Klett 
colorimeter.  
6.12 Fluorescence microscopy 
 For agarose pad imaging of fluorescence, strains were cultured as previously 




onto an agarose pad (1.5% agarose in PBS), transferred to sterile glass microscope 
slide, and placed in a glass bottom dish. An Axio Observer.Z microscope (Zeiss) was 
used to image strains at 100x magnification using phase contrast and fluorescence. 
Photographs were taken using Zen 2012 imaging software (Zeiss).  
 
6.13 Flow cytometry 
 Single colonies of B. subtilis strains were inoculated into 2xYT broth with 
appropriate antibiotic for 18 h at 37°C. The following day the overnight cultures were 
inoculated into fresh 2xYT broth to an OD600 of ~0.1. The resulting culture was 
incubated at 37°C shaking allowed to reach an OD600 of ~ 0.5. Once the cultures 
reach exponential phase, the cultures were induced with 30 µg/mL bacitracin in the 
presence of absence of 5 mM EA, and allowed to incubate shaking at 37°C for an 
additional 45 minutes. Then 1 mL of each culture was centrifuged at 5700 rpm for 5 
minutes, rich media decanted, and resuspended in 1x phosphate-buffered saline 
solution, PBS, (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and 2 mM KH2PO4). 
500 µL of washed culture was then added to 2 mL 1X PBS. 
Cells were then analyzed on a FACSCanto II, where 30,000 events were 
counted per sample. All samples and conditions were compared to a strain that does 







Table 5. List of oligonucleotides used in these 
studies.   
Primer Purpose Sequence- 5' to 3' 
MG18 
Probe for northern blotting, B. 
subtilis 5S RNA (Sharp & 
Bechhofer, 2003) 
CGACTACCATCGGCGCTGAA 
MG238 E. faecalis OG1RF 5S rRNA Northern blot probe GTGTATCCTTCTCGCTATCGCCACCA 
MG244 F. oligo for 3' of AdoCbl riboswitch (use for 3' RACE) 
GTGCTTTTGGGAATTTTGGGCTGGTCTT 
MG245 R. oligo for 5' of AdoCbl riboswitch (use for 3' RACE) 
CAGTGGCGGGACCGTGCCAGA 
MG260 
Reverse transcription oligo for 
determining 3' end of E. faecalis 
+EA EutX 
ATTGATGGTGCCTACAG 
MG261 R. oligo for amplifying E. faecalis EutX cDNA with MG260 CTCACTGGCTTCCATTC 
MG279 Probe for northern blotting in CORE of AdoCbl riboswitch CCTGACTTAAAAGCAACCTTGCTTC 
JRG174 Probe for northern blotting in EutX, inside AdoCbl riboswitch 
CAAAATTCCCAAAAGCACTTCCTCGTGCC 
JRG175 Probe for northern blotting in EutX, 3’ of riboswitch 
GTTAAGAAACATCCTGTTTTGCCTCG 
MG280 Probe for northern blotting in between probes JRG174/175 
CAAATATCTTGGGCTGGATTTTCAAC 
MG281 Probe for northern blotting in downstream of P4 
CAATAAAAAAAGGGAATATAGCAGTACGT
C 
MG282 R. oligo for amplifying EutX cDNA with MG260 
GAATCTGGCACGGTCCCGCC 
MG283 R. oligo for amplifying EutX cDNA with MG260 
CAAGGTTGCTTTTAAGTCAGGTC 
MG284 R. oligo for amplifying EutX cDNA with MG260 
CGAGGCAAAACAGGATGTTTCTTAAC 
MG285 
Reverse transcription oligo for 
determining 3' end of E. faecalis 
+EA EutX 
GCATGCATTGATGGTGCCTACAG 
MG290 F. oligo for transcription of EutX with T7 promoter 
TAATACGACTCACTATAGGGGAATTCGAG
TACAACGCC 





MG293 R. oligo for 3’ of AdoCbl riboswitch (use for 3’ RACE)  
CAACCTTGCTTCTTCACAGTGG  
MG294 
F. OLIGO FOR 5' OF B12 




F. oligo for 5’ of AdoCbl 
riboswitch (use for 3’ RACE) 
Third F. oligo for circularization  
GTTAAGAAACATCCTGTTTTGCCTCG  
MG298 F. oligo for PglyQS ATTGATTTATATTACGAAGAATATTC 
MG299 R. oligo for 45 bp downstream of 3' end of AdoCbl riboswitch 
TTTTCAACACAAGCGTTGTTAAG 
MG301 
F. oligo for gibson assembling 





R. oligo for gibson assembling 





R. oligo for PCR amplification of 
AdoCbl riboswitch component of 
EutX 
AAGAAACATCCTGTTTTGCCTCG 
MG396 F. oligo for amplification of P1P2T into pJG019 
GGCATAATGTGTGTGCACAAAGAATCAGA
AACACAATGG 




R. oligo for amplification of 




MG434 F. oligo for PliaI (bacitracin inducible promoter) 
GAAGGCCAAAAAACTGCTGCCTTCGGATC
CATTGGCCAAAGCAGAAAG 




F. oligo for gibson assembling 
PliaI into pDG1664 with pDG1664 




F. oligo for gibson assembling 
PliaI into pDG1664 with pDG1664 




F. oligo for gibson assembling 
EutV into pDG1664 with PliaI at 
5' and EutW at 3' 
AGGAAAACGAGTGAAGAAAATGGATGGAC 
MG452 
R. oligo for gibson assembling 
EutV into pDG1664 with PliaI at 5' 







F. oligo for gibson assembling 
EutW into pDG1664 with EutV at 




R. oligo for gibson assembling 
EutW into pDG1664 with EutV at 
5' and pDG1664 at 3' 
CCATAACTTTAGGGTTATCGTCAATGAAC
AACATCACTGG 
MG564 F. oligo for qPCR of EutV set1 TAGGCGCACTGGGTTATTTAG  
MG565 R. oligo for qPCR of EutV set1 AGTAACAGCTGCGTTTGTTTG 
MG566 F. oligo for qPCR of EutV set2 TCAAGACCAACTAGCCAGTAGTA  
MG567 R. oligo for qPCR of EutV set2 CTAAATAACCCAGTGCGCCTAA 
MG576 F. oligo for qPCR of EutW set1 GCAATCGGTGGTTTCCTTATTG 
MG577 R. oligo for qPCR of EutW set1 GGCTGCAATCGCCATAATTC 
MG578 F. oligo for qPCR of EutW set2 ACTAGTCAAGTCGACGCATTATT 
MG579 R. oligo for qPCR of EutW set2 GCTCTTGTGCATTGTGATTGG 
MG665 F. oligo for qPCR of EutX set2 TCCAGCCCAAGATATTTGTATT 
MG666 R. oligo for qPCR of EutX set2 CAGTACGTCATTGTACCTGAAA 
MG667 P1/P2 DNA probe for northern blot 
GCCGATTGTTAAAACACGCC 




R. oligo to amplify pJG019 
backbone with HindIII RE-site 
and P1P2T  
GCGTGCTTAAGCTTAGCTTAAGGAGGAAA
GTCACATTATGAG 
MG681 F. oligo to Q5 SDM make EutV-Y101A on pMG1050 
CGCACTGGGTGCATTAGTTAAACCTCTAG 
MG682 R. oligo to Q5 SDM make EutV-Y101A on pMG1050 
CCTAATTTTTTAGCTTTGTCC 
MG683 F. oligo to Q5 SDM make EutV-K104A on pMG1050 
TTATTTAGTTGCACCTCTAGATGAAAAAT
CATTAATAC 
MG684 R. oligo to Q5 SDM make EutV-K104A on pMG1050 
CCCAGTGCGCCTAATTTTTTAG 
MG685 F. oligo to Q5 SDM make EutV-M117A on pMG1050 
TACAATTGAAGCAAGCATTGAACGAGGC 
MG686 R. oligo to Q5 SDM make EutV-M117A on pMG1050 
GGTATTAATGATTTTTCATCTAGAG 
MG687 F. oligo to Q5 SDM make EutV-Q124A on pMG1050 
ACGAGGCAAAGCAACGCAGCTGTTAC 
MG688 R. oligo to Q5 SDM make EutV-Q124A on pMG1050 
TCAATGCTCATTTCAATTGTAGG 
MG689 F. oligo to Q5 SDM make EutV-Q131A on pMG1050 
GTTACTAAATGCAATCGATAAATTAAGTT
TAAAATTAGAAG 





MG691 F. oligo to Q5 SDM make EutV-E140A on pMG1050 
TTTAAAATTAGCAGAACGTAAAATTATCG
AAAAAG 
MG692 R. oligo to Q5 SDM make EutV-E140A on pMG1050 
CTTAATTTATCGATTTGATTTAGTAAC 
MG693 F. oligo to Q5 SDM make EutV-R142A on pMG1050 
ATTAGAAGAAGCAAAAATTATCGAAAAAG
CCAAAGG 
MG694 R. oligo to Q5 SDM make EutV-R142A on pMG1050 
TTTAAACTTAATTTATCGATTTGATTTAG 
MG695 F. oligo to Q5 SDM make EutV-K149A on pMG1050 
CGAAAAAGCCGCAGGTATTCTTGTAAAAG 
MG696 R. oligo to Q5 SDM make EutV-K149A on pMG1050 
ATAATTTTACGTTCTTCTAATTTTAAAC 
MG697 F. oligo to Q5 SDM make EutV-E160A on pMG1050 
TCATATATCGGCAGAAGAAGCCTAC 
MG698 R. oligo to Q5 SDM make EutV-E160A on pMG1050 
TTTTCTTTTACAAGAATACCTTTG 
MG699 F. oligo to Q5 SDM make EutV-Y164A on pMG1050 
AGAAGAAGCCGCACAAATGTTGCGTACG 
MG700 R. oligo to Q5 SDM make EutV-Y164A on pMG1050 
TCCGATATATGATTTTCTTTTACAAG 
MG701 F. oligo to Q5 SDM make EutV-S171A on pMG1050 
GCGTACGTTAGCAATGAACAAACGC 
MG702 R. oligo to Q5 SDM make EutV-S171A on pMG1050 
AACATTTGGTAGGCTTCTTC 
MG703 F. oligo to Q5 SDM make EutV-M172A on pMG1050 
TACGTTAAGTGCAAACAAACGCGCAC 
MG704 R. oligo to Q5 SDM make EutV-M172A on pMG1050 
CGCAACATTTGGTAGGCTTC 
MG705 F. oligo to Q5 SDM make EutV-N173A on pMG1050 
GTTAAGTATGGCAAAACGCGCACG 
MG706 R. oligo to Q5 SDM make EutV-S173A on pMG1050 
GTACGCAACATTTGGTAG 
MG707 F. oligo to Q5 SDM make EutV-R175A on pMG1050 
TATGAACAAAGCAGCACGTATGAGTGAAA
TTG 
MG708 R. oligo to Q5 SDM make EutV-R175A on pMG1050 
CTTAACGTACGCAACATTTG 
MG709 F. oligo to Q5 SDM make EutV-M178A on pMG1050 
ACGCGCACGTGCAAGTGAAATTG 
MG710 R. oligo to Q5 SDM make EutV-M178A on pMG1050 
TTGTTCATACTTAACGTACG 




MG712 R. oligo to amplify pDG148  TTTTCATAAAATATTCGTTTCTCTAGATCACCTCCTTAAGCTTAATTGTTATCC 
MG713 F. oligo to amplify and gibson assemble EutX into pDG148 
CTTAAGGAGGTGATCTAGAGAAACGAATA
TTTTATGAAAAATATGAATGGAAGCCAG 
MG714 R. oligo to amplify and gibson assemble EutX into pDG148 
GTTTCCACCGAATTAGCTTGGGGAATATA
GCAGTACGTCATTGTACCTGAAATCTCC 
MG681 F. oligo to Q5 SDM make EutV-Y101A on pMG1050 
CGCACTGGGTGCATTAGTTAAACCTCTAG 
MG682 R. oligo to Q5 SDM make EutV-Y101A on pMG1050 
CCTAATTTTTTAGCTTTGTCC 
MG683 F. oligo to Q5 SDM make EutV-K104A on pMG1050 
TTATTTAGTTGCACCTCTAGATGAAAAAT
CATTAATAC 
MG684 R. oligo to Q5 SDM make EutV-K104A on pMG1050 
CCCAGTGCGCCTAATTTTTTAG 
MG685 F. oligo to Q5 SDM make EutV-M117A on pMG1050 
TACAATTGAAGCAAGCATTGAACGAGGC 
MG686 R. oligo to Q5 SDM make EutV-M117A on pMG1050 
GGTATTAATGATTTTTCATCTAGAG 
MG687 F. oligo to Q5 SDM make EutV-Q124A on pMG1050 
ACGAGGCAAAGCAACGCAGCTGTTAC 
MG688 R. oligo to Q5 SDM make EutV-Q124A on pMG1050 
TCAATGCTCATTTCAATTGTAGG 
MG689 F. oligo to Q5 SDM make EutV-Q131A on pMG1050 
GTTACTAAATGCAATCGATAAATTAAGTT
TAAAATTAGAAG 
MG690 R. oligo to Q5 SDM make EutV-Q131A on pMG1050 
AGCTGCGTTTGTTTGCCTC 
MG691 F. oligo to Q5 SDM make EutV-E140A on pMG1050 
TTTAAAATTAGCAGAACGTAAAATTATCG
AAAAAG 
MG692 R. oligo to Q5 SDM make EutV-E140A on pMG1050 
CTTAATTTATCGATTTGATTTAGTAAC 
MG693 F. oligo to Q5 SDM make EutV-R142A on pMG1050 
ATTAGAAGAAGCAAAAATTATCGAAAAAG
CCAAAGG 
MG694 R. oligo to Q5 SDM make EutV-R142A on pMG1050 
TTTAAACTTAATTTATCGATTTGATTTAG 
MG695 F. oligo to Q5 SDM make EutV-K149A on pMG1050 
CGAAAAAGCCGCAGGTATTCTTGTAAAAG 
MG696 R. oligo to Q5 SDM make EutV-K149A on pMG1050 
ATAATTTTACGTTCTTCTAATTTTAAAC 
MG697 F. oligo to Q5 SDM make EutV-E160A on pMG1050 
TCATATATCGGCAGAAGAAGCCTAC 





MG699 F. oligo to Q5 SDM make EutV-Y164A on pMG1050 
AGAAGAAGCCGCACAAATGTTGCGTACG 
MG700 R. oligo to Q5 SDM make EutV-Y164A on pMG1050 
TCCGATATATGATTTTCTTTTACAAG 
MG701 F. oligo to Q5 SDM make EutV-S171A on pMG1050 
GCGTACGTTAGCAATGAACAAACGC 
MG702 R. oligo to Q5 SDM make EutV-S171A on pMG1050 
AACATTTGGTAGGCTTCTTC 
MG703 F. oligo to Q5 SDM make EutV-M172A on pMG1050 
TACGTTAAGTGCAAACAAACGCGCAC 
MG704 R. oligo to Q5 SDM make EutV-M172A on pMG1050 
CGCAACATTTGGTAGGCTTC 
MG705 F. oligo to Q5 SDM make EutV-N173A on pMG1050 
GTTAAGTATGGCAAAACGCGCACG 
MG706 R. oligo to Q5 SDM make EutV-S173A on pMG1050 
GTACGCAACATTTGGTAG 
MG707 F. oligo to Q5 SDM make EutV-R175A on pMG1050 
TATGAACAAAGCAGCACGTATGAGTGAAA
TTG 
MG708 R. oligo to Q5 SDM make EutV-R175A on pMG1050 
CTTAACGTACGCAACATTTG 
MG709 F. oligo to Q5 SDM make EutV-M178A on pMG1050 
ACGCGCACGTGCAAGTGAAATTG 
MG710 R. oligo to Q5 SDM make EutV-M178A on pMG1050 
TTGTTCATACTTAACGTACG 
MG711 F. oligo to amplify pDG148  TGACGTACTGCTATATTCCCCAAGCTAATTCGGTGGAAACGAGG 
MG712 R. oligo to amplify pDG148  TTTTCATAAAATATTCGTTTCTCTAGATCACCTCCTTAAGCTTAATTGTTATCC 
MG713 F. oligo to amplify and gibson assemble EutX into pDG148 
CTTAAGGAGGTGATCTAGAGAAACGAATA
TTTTATGAAAAATATGAATGGAAGCCAG 
MG714 R. oligo to amplify and gibson assemble EutX into pDG148 
GTTTCCACCGAATTAGCTTGGGGAATATA
GCAGTACGTCATTGTACCTGAAATCTCC 
MG727 F. oligo to Q5 SDM make EutV-K143A on pMG1050 
AGAAGAACGTGCAATTATCGAAAAAGC 
MG728 R. oligo to Q5 SDM make EutV-K143A on pMG1050 
AATTTTAAACTTAATTTATCGATTTGATT
TAG 
MG729 F. oligo to Q5 SDM make EutV-K147A on pMG1050 
AATTATCGAAGCAGCCAAAGGTATTC 
MG730 R. oligo to Q5 SDM make EutV-K147A on pMG1050 
TTACGTTCTTCTAATTTTAAACTTAATTT
ATC 






MG732 R. oligo to Q5 SDM make EutV-K154A on pMG1050 
CCTTTGGCTTTTTCGATAATTTTAC 
MG733 F. oligo to Q5 SDM make EutV-Q165A on pMG1050 
AGAAGCCTACGCAATGTTGCGTAC 
MG734 R. oligo to Q5 SDM make EutV-Q165A on pMG1050 
TCTTCCGATATATGATTTTCTTTTAC 
MG735 F. oligo to Q5 SDM make EutV-R168A on pMG1050 
CCAAATGTTGGCAACGTTAAGTATGAACA
AACG 
MG736 R. oligo to Q5 SDM make EutV-R168A on pMG1050 
TAGGCTTCTTCTTCCGATATATG 
MG737 F. oligo to Q5 SDM make EutV-Q165A/R168A on pMG1050 
TTGGCAACGTTAAGTATGAACAAACGC 
MG738 R. oligo to Q5 SDM make EutV-Q165A/R168A on pMG1050 
CATTGCGTAGGCTTCTTCTTCCGATATAT
G 
MG739 F. oligo to Q5 SDM make EutV-Q165R/R168Q on pMG1050 
TTGCAAACGTTAAGTATGAACAAACGC 
MG740 R. oligo to Q5 SDM make EutV-Q165R/R168Q on pMG1050 
CATACGGTAGGCTTCTTCTTCCGATATAT
G 
MG741 F. oligo to amplify pMG1050 (backbone not including EutV/W)  
GGAGAGTCACACCTAAAGAAAAGCTTATC
GAATTCGATAACCCTAAAGTTATG 




F. oligo to amplify NasR from 





R. oligo to amplify NasR from 





F. oligo to amplify NasF leader 
region containing 
P1/P2/Terminator to be gibson 




R. oligo to amplify NasF leader 
region containing 
P1/P2/Terminator to be gibson 




F. oligo to amplify pMG1044 





R. oligo to amplify pMG1044 









MG750 R. oligo to Q5 SDM make P2 C1U4 in pMG1088 to P2 C1G4 
TGTTAAAACACGCAATGGTGTTTC 
MG751 
F. oligo to amplify pMG1050 





R. oligo to amplify pMG1050 




MG727 F. oligo to Q5 SDM make EutV-K143A on pMG1050 
AGAAGAACGTGCAATTATCGAAAAAGC 
MG728 R. oligo to Q5 SDM make EutV-K143A on pMG1050 
AATTTTAAACTTAATTTATCGATTTGATT
TAG 
MG729 F. oligo to Q5 SDM make EutV-K147A on pMG1050 
AATTATCGAAGCAGCCAAAGGTATTC 
MG730 R. oligo to Q5 SDM make EutV-K147A on pMG1050 
TTACGTTCTTCTAATTTTAAACTTAATTT
ATC 
MG731 F. oligo to Q5 SDM make EutV-K154A on pMG1050 
TATTCTTGTAGCAGAAAATCATATATCGG
AAG 
MG732 R. oligo to Q5 SDM make EutV-K154A on pMG1050 
CCTTTGGCTTTTTCGATAATTTTAC 
MG733 F. oligo to Q5 SDM make EutV-Q165A on pMG1050 
AGAAGCCTACGCAATGTTGCGTAC 
MG734 R. oligo to Q5 SDM make EutV-Q165A on pMG1050 
TCTTCCGATATATGATTTTCTTTTAC 
MG735 F. oligo to Q5 SDM make EutV-R168A on pMG1050 
CCAAATGTTGGCAACGTTAAGTATGAACA
AACG 
MG736 R. oligo to Q5 SDM make EutV-R168A on pMG1050 
TAGGCTTCTTCTTCCGATATATG 
MG737 F. oligo to Q5 SDM make EutV-Q165A/R168A on pMG1050 
TTGGCAACGTTAAGTATGAACAAACGC 
MG738 R. oligo to Q5 SDM make EutV-Q165A/R168A on pMG1050 
CATTGCGTAGGCTTCTTCTTCCGATATAT
G 
MG739 F. oligo to Q5 SDM make EutV-Q165R/R168Q on pMG1050 
TTGCAAACGTTAAGTATGAACAAACGC 
MG740 R. oligo to Q5 SDM make EutV-Q165R/R168Q on pMG1050 
CATACGGTAGGCTTCTTCTTCCGATATAT
G 
MG741 F. oligo to amplify pMG1050 (backbone not including EutV/W)  
GGAGAGTCACACCTAAAGAAAAGCTTATC
GAATTCGATAACCCTAAAGTTATG 




F. oligo to amplify NasR from 








R. oligo to amplify NasR from 





F. oligo to amplify NasF leader 
region containing P1P2T to be 




R. oligo to amplify NasF leader 
region containing P1P2T to be 
gibson cloned into pMG1044 
GGGGCGGGGTTTTTGCTAGCTTATTTATA
CAGTTCGTCCATACCGTGGGT 
MG747 F. oligo to amplify pMG1044 TGGACGAACTGTATAAATAAGCTAGCAAAAACC 
MG748 R. oligo to amplify pMG1044  CCAAAACCTTTTATTCACTCTGCACACACATTATGCCACACCT 
MG749 F. oligo to Q5 SDM make P2 C1U4 in pMG1088 to P2 C1G4 
AATCGGCCAAGGAGCCCAAGA 
MG750 R. oligo to Q5 SDM make P2 C1U4 in pMG1088 to P2 C1G4 
TGTTAAAACACGCAATGGTGTTTC 
MG751 F. oligo to amplify pMG1050 backbone 
AAAAGGAGGAAAGTCACATTATGAAACGA
TTAGAG 




F. oligo to gibson clone K. 






R. oligo to amplify Koxytoca 




MG772 F. oligo to revert R168A in EutV of pMG1124 to R168R (168)  
CGCAATGTTGCGTACGTTAAGTATGAACA
AAC 
MG773 R. oligo to revert R168A in EutV of pMG1124 to R168R (168)  
TAGGCTTCTTCTTCCGATATATG 
MG774 F. oligo to Q5 SDM make EutV-R142K on pMG1050 
ATTAGAAGAAAAAAAAATTATCGAAAAAG
CCAAAG 
MG775 R. oligo to Q5 SDM make EutV-R142K on pMG1050 
TTTAAACTTAATTTATCGATTTGATTTAG 
MG776 F. oligo to Q5 SDM make EutV-K143R on pMG1050 
AGAAGAACGTAGAATTATCGAAAAAG 
MG777 R. oligo to Q5 SDM make EutV-K143R on pMG1050 
AATTTTAAACTTAATTTATCGATTTGATT
TAG 
MG778 F. oligo to Q5 SDM make EutV-K147R on pMG1050 
AATTATCGAAAGAGCCAAAGGTATTC 






MG780 F. oligo to Q5 SDM make EutV-K149R on pMG1050 
CGAAAAAGCCAGAGGTATTCTTG 
MG781 R. oligo to Q5 SDM make EutV-K149R on pMG1050 
ATAATTTTACGTTCTTCTAATTTTAAAC 
MG786 F. oligo to Q5 SDM make EutV-R168K on pMG1050 
CCAAATGTTGAAAACGTTAAGTATGAACA
AAC 
MG787 R. oligo to Q5 SDM make EutV-R168K on pMG1050 
TAGGCTTCTTCTTCCGATATATG 
MG790 
F. oligo to SDM make CCC to 




R. oligo to SDM make CCC to 




F. oligo to amplify pDG148 for 





R. oligo to amplify pDG148 for 





F. oligo to amplify and gibson 





R. oligo to amplify and gibson 





F. oligo to amplify NasF P1P2T 





R. oligo to amplify NasF P1P2T 




MG803 F. oligo to Q5 SDM delete LINKER from pMG1133 
GGGCTGGTCTTTCAATGTTG 
MG804 R. oligo to Q5 SDM delete LINKER from pMG1133 
GAAGATCATGTGATTTCTCTTTGTTC 
MG811 
F. oligo to amplify NasF P1P2 
(no terminator) with T7 promoter, 




R. oligo to amplify NasF P1P2 
(no terminator) with T7 promoter, 
PCR product is 61 bp 
GGACGCCTTTATCCCTGGACATAC 







F. oligo to amplify EutS 





R. oligo to amplify EutS 




MG864 F. oligo for NasF P1P2 with extended leader (with T7 oligo) 
TAATACGACTCACTATAGGGAGTGAATAA
AAGG 









































Table 6. List of gBlocks used in these studies   
Name Purpose Sequence- 5' to 3' 






















Full length EutX M3 mutant (C3 to 





















PglyQS 5' of WT EutX. gBlock used 

























PglyQS 5' of pseudoknot mutation 




















NasR DNA sequence from K. 






























































































M9 (AG to CC) mutant GlmS 
ribozyme fused to P3P4 (including 





















	 	  
	 	  





























Table 7. List of plasmids used in these studies.   
Name Description Reference 
pMG1040 EutX (132) 
pMG1041 M3 EutX (132) 
pMG1044 amyE:: Pconst P1P2T-YFP This Study 
pMG1050 thrC:: PliaI EutV/EutW This Study 
pMG1100 thrC:: PliaI EutV Y101A/EutW This Study 
pMG1101 thrC:: PliaI EutV K104A/EutW This Study 
pMG1102 thrC:: PliaI EutV M117A/EutW This Study 
pMG1103 thrC:: PliaI EutV Q124A/EutW This Study 
pMG1104 thrC:: PliaI EutV Q131A/EutW This Study 
pMG1105 thrC:: PliaI EutV E140A/EutW This Study 
pMG1106 thrC:: PliaI EutV R142A/EutW This Study 
pMG1107 thrC:: PliaI EutV K149A/EutW This Study 
pMG1108 thrC:: PliaI EutV E160A/EutW This Study 
pMG1109 thrC:: PliaI EutV Y164A/EutW This Study 
pMG1110 thrC:: PliaI EutV S171A/EutW This Study 
pMG1111 thrC:: PliaI EutVM172A/EutW This Study 
pMG1112 thrC:: PliaI EutV N173A/EutW This Study 
pMG1113 thrC:: PliaI EutV R175A/EutW This Study 
pMG1114 thrC:: PliaI EutV M178A/EutW This Study 
pMG1115 EutX with semi-synthetic terminator in 
pDG148 
This Study 
pMG1119 thrC:: PliaI EutV K143A/EutW This Study 
pMG1120 thrC:: PliaI EutV K147A/EutW This Study 
pMG1121 thrC:: PliaI EutV K154A/EutW This Study 
pMG1122 thrC:: PliaI EutV Q165A/EutW This Study 
pMG1123 thrC:: PliaI EutV R168A/EutW This Study 
pMG1124 thrC:: PliaI EutV Q165A R168A/EutW This Study 
pMG1125 thrC:: PliaI EutV Q165R R168Q/EutW This Study 
pMG1126 thrC:: PliaI NasR (from K. oxytoca) This Study 
pMG1127 amyE:: Pconst P1P2nasF-YFP  This Study 
pMG1130 His10-MBP- NasR (from K. oxytoca) This Study 
pMG1136 thrC:: PliaI EutV R142K/EutW This Study 
pMG1137 thrC:: PliaI EutV K143R/EutW This Study 
pMG1138 thrC:: PliaI EutV K147R/EutW This Study 
pMG1139 thrC:: PliaI EutV K149R/EutW This Study 
pMG1140 thrC:: PliaI EutV R168K/EutW This Study 




pDG148 (* denotes C1U4 mutations in  loops) 
pMG1142 His10-MBP- NasR R340A (from K. oxytoca) This Study 
pMG1143 His10-MBP- NasR R340K (from K. oxytoca) This Study 













































Table 8. List of strains used in these studies. 	   
Name Description Organism Reference 
168 Wild-type  B. subtilis (Kunst et al. 
1997) 
OG1RF Wild-type E. faecalis (Bourgogne et 
al. 2008) 
ΔEutX Deletion of EutX from 
chromosome 
E. faecalis (DebRoy et al. 
2014) 
ΔEutV/W Deletion of EutV/W from 
chromosome 
E. faecalis (DebRoy et al. 
2014) 
EFKK6 EutM-GFP in ectopic location, 
under endogenous promoter 
control 
E. faecalis This Study 
ΔEutX plasmid Deletion of EutX from 
extrachromosomal plasmid 
E. faecalis (DebRoy et al. 
2014) 
ΔRb plasmid Deletion of AdoCbl Rb from 
extrachromosomal plasmid 
E. faecalis (DebRoy et al. 
2014) 
ΔP3P4 plasmid Deletion of P3P4 from 
extrachromosomal plasmid 
E. faecalis (DebRoy et al. 
2014) 
MG5141 amyE:: Pconst P1P2-Term-YFP E. coli This Study 
MG5147 amyE:: Pconst P1P2-Term-YFP B. subtilis This Study 
MG5182 thrC::PliaI -EutV/W E. coli This Study 
MG5183 thrC:: PliaI -EutV/W B. subtilis This Study 
MG5187 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI -EutV/W 
B. subtilis This Study 
MG5195 amyE::P1P2-Term-YFP (no 
promoter) 
E. coli This Study 
MG5196 amyE::P1P2-Term-YFP (no 
promoter), thrC:: PliaI -EutV/W 
B. subtilis This Study 
MG5197 amyE:: Pconst P1P2-Term-YFP 
with C1U4 in P1P2 loops 
E. coli This Study 
MG5198 amyE:: Pconst P1P2-Term-YFP 
with C1U4 in P1P2 loops,  
thrC:: PliaI -EutV/W 
B. subtilis This Study 
MG5200 amyE::Pconst P1P2-Term-YFP 
with C1U4 in P1 loop (WT P2) 
E. coli This Study 
MG5201 amyE:: Pconst P1P2-Term-YFP 
with C1U4 in P1 loop (WT P2),  
thrC:: PliaI -EutV/W  
B. subtilis This Study 
MG5225 thrC:: PliaI EutV Y101A /EutW E. coli This Study 
MG5226 thrC:: PliaI EutV K104A /EutW  E. coli This Study 
MG5227 thrC:: PliaI EutV M117A /EutW E. coli This Study 
MG5228 thrC:: PliaI EutV Q124A /EutW E. coli This Study 




MG5230 thrC:: PliaI EutV E140A /EutW  E. coli This Study 
MG5231 thrC:: PliaI EutV R142A /EutW  E. coli This Study 
MG5232 thrC:: PliaI EutV K149A /EutW  E. coli This Study 
MG5233 thrC:: PliaI EutV E160A /EutW  E. coli This Study 
MG5234 thrC:: PliaI EutV Y164A /EutW  E. coli This Study 
MG5235 thrC:: PliaI EutV S171A /EutW  E. coli This Study 
MG5236 thrC:: PliaI EutV M172A /EutW E. coli This Study 
MG5237 thrC:: PliaI EutV N173A /EutW  E. coli This Study 
MG5238 thrC:: PliaI EutV R175A /EutW E. coli This Study 
MG5239 thrC:: PliaI EutV M178A /EutW  E. coli This Study 
MG5240 EutX with SST in pDG148  E. coli This Study 
MG5241 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV Y101A /EutW 
B. subtilis This Study 
MG5242 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV K104A /EutW 
B. subtilis This Study 
MG5243 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV M117A /EutW 
B. subtilis This Study 
MG5244 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV Q124A /EutW 
B. subtilis This Study 
MG5245 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV Q131A /EutW 
B. subtilis This Study 
MG5246 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV E140A /EutW 
B. subtilis This Study 
MG5247 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV R142A /EutW 
B. subtilis This Study 
MG5248 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV E149A /EutW 
B. subtilis This Study 
MG5249 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV E160A /EutW 
B. subtilis This Study 
MG5250 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV Y164A /EutW 
B. subtilis This Study 
MG5251 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV S171A /EutW 
B. subtilis This Study 
MG5252 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV M172A /EutW 
B. subtilis This Study 
MG5253 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV N173A /EutW 
B. subtilis This Study 
MG5254 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV R175A /EutW 
B. subtilis This Study 
MG5255 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV M178A /EutW 
B. subtilis This Study 
MG5257 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV/W, EutX with 
SST in pDG148 




MG5269 thrC:: PliaI EutV K143A /EutW  E. coli This Study 
MG5270 thrC:: PliaI EutV K147A /EutW  E. coli This Study 
MG5271 thrC:: PliaI EutV K154A /EutW  E. coli This Study 
MG5272 thrC:: PliaI EutV Q165A /EutW  E. coli This Study 
MG5273 thrC:: PliaI EutV R168A /EutW  E. coli This Study 
MG5274 thrC:: PliaI EutV Q165AR168A 
/EutW  
E. coli This Study 
MG5275 thrC:: PliaI EutV Q165RR168Q 
/EutW  
E. coli This Study 
MG5276 thrC:: PliaI NasR (from K. 
oxytoca) 
E. coli This Study 
MG5277 amyE:: Pconst P1P2nasF- YFP E. coli This Study 
MG5278 amyE:: Pconst P1P2-Term-YFP 
with C1U4 in P1 loop and 
C1G4 in P2 loop 
E. coli This Study 
MG5280 His10 MBP NasR (From K. 
oxytoca) in pVL847CbR 
E. coli This Study 
MG5281 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV K143A /EutW  
B. subtilis This Study 
MG5282 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV K147A /EutW  
B. subtilis This Study 
MG5283 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV K154A /EutW  
B. subtilis This Study 
MG5284 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV Q165A /EutW  
B. subtilis This Study 
MG5285 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV R168A /EutW  
B. subtilis This Study 
MG5286 amyE:: Pconst -P1P2-Term-YFP, 
thrC:: PliaI EutV Q165A R168A 
/EutW  
B. subtilis This Study 
MG5287 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV Q165RR168Q 
/EutW  
B. subtilis This Study 
MG5288 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI NasR (from K. 
oxytoca) 
B. subtilis This Study 
MG5289 amyE:: Pconst P1P2nasF- YFP, 
thrC:: PliaI EutV/EutW  
B. subtilis This Study 
MG5290 amyE:: Pconst P1P2-Term-YFP 
with C1U4 in P1 loop and 
C1G4 in P2 loop, thrC:: PliaI 
EutV/EutW  
B. subtilis This Study 
MG5292 His10 MBP NasR (From K. 
oxytoca) in pVL847CbR 
E. coli This Study 






MG5295 GlmS*P3P4 with SST (GlmS is 
M9 mutant) in pDG148 
E. coli This Study 
MG5296 GlmS*P3P4 with SST (GlmS is 
M9 mutant) into NEB PCR 
cloning vector 
E. coli This Study 
MG5297 EutX w/ SST and CCC->GGG 
mutant in Riboswitch 
pseudoknot in pDG148  
E. coli This Study 
MG5298 GlmS-P3P4 with SST (GlmS is 
WT) in pDG148 
E. coli This Study 
MG5299 thrC:: PliaI EutV R142K /EutW E. coli This Study 
MG5300 thrC:: PliaI EutV K143R /EutW  E. coli This Study 
MG5301 thrC:: PliaI EutV K147R /EutW  E. coli This Study 
MG5302 thrC:: PliaI EutV K149R /EutW  E. coli This Study 
MG5303 thrC:: PliaI EutV R168K /EutW  E. coli This Study 
MG5304 amyE:: Pconst P1P2nasF- YFP B. subtilis This Study 
MG5305 amyE:: Pconst P1P2nasF- YFP,  
thrC::PliaI-NasR (from K. 
oxytoca) 
B. subtilis This Study 
MG5306 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV/W, EutX 
(CCC->GGG mutant) with SST 
in pDG148 (self-replicating 
plasmid) 
B. subtilis This Study 
MG5307 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV R142K /EutW  
B. subtilis This Study 
MG5308 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV K143R /EutW  
B. subtilis This Study 
MG5309 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV K147R /EutW  
B. subtilis This Study 
MG5310 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV K149R /EutW  
B. subtilis This Study 
MG5311 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV R168K /EutW  
B. subtilis This Study 
MG5312 amyE:: Pconst P1P2-Term-YFP, 
thrC:: PliaI EutV/W, 
GlmS*P3P4 with SST (GlmS is 
M9 mutant) in pDG148 
B. subtilis This Study 
MG5314 thrC:: PliaI NasR (from K. 
oxytoca) 
B. subtilis This Study 
MG5321 His10 MBP NasR R340A in 
pVL847CbR 
E. coli This Study 





MG5335 amyE::PeutS-P7P8T-YFP E. coli This Study 
MG5336 BKE29740 (delta-ccpA) 
pDR224 
B. subtilis This Study 
MG5347 amyE::PeutS-P7P8T-YFP, 
thrC::PLiaI-EutV/W 
B. subtilis This Study 
MG5349 delta-ccpA (BKE29740), 
amyE::PeutS-P7P8T-YFP,  
thrC::PliaI-EutV/W  
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